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ABSTRACT

Chemical communication mediates the vast majority of collective bacterial
behaviors, orchestrating gene expression and community functions. A fundamental
understanding of how pathogens are able to do this underlies the philosophy of natural
product chemistry, providing insights into novel mechanisms for controlling
pathogenic bacterial infections. To increase the effectiveness of antibiotics, alternative
therapeutic approaches can be used that target bacterial phenotypes associated with
infections, including swarming motility and quiescence. This dissertation explores
molecules that interfere with such phenotypes in two different pathogens:
uropathogenic Escherichia coli (UPEC) and Vibrio parahaemolyticus. Increased
understanding of how bacterial behaviors can be modulated in pathogens may
significantly improve our ability to tackle these diseases.
The first study, which is reported in chapter two, describes the role of
peptidoglycan, a ubiquitous bacterial cell wall component, in facilitating the reversal
of quiescence in UPEC. This study uses an in vitro model of the quiescent state to test
isolated peptidoglycan as a chemical signaling molecule that reverses dormancy. A
single purified peptide was isolated from cultures of UPEC using bioassay-guided
fractionation and enzyme treatment. The tetrapeptide, Ala-Glu-DAP-Ala was found to
be a potent proliferant that reverses quiescence in UPEC. This is the first reported
compound to possess this bioactivity.
Chapter three describes an investigation to better understand chemically-mediated
bacteria-bacteria interactions between the marine bacteria Bacillus pumilus YP001 and
Vibrio parahaemolyticus PSU5429. The investigational approach used a combination

of experimental methods, emphasizing Matrix-Assisted Laser Desorption IonizationTime of Flight Imaging Mass Spectrometry (MALDI-TOF IMS), whole genome
analysis, and chemical isolations. The main finding showed that multiple compounds
produced by the B. pumilus may act in concert to effect a lethal outcome on V.
parahaemolyticus cells. When B. pumilus was grown in close proximity to the V.
parahaemolyticus on an agar surface, secreted secondary metabolites induced
swarming motility in the vibrio, chemically attracting toward a lethal zone containing
an antibiotic.
Chapter four describes whole genome sequencing and bioinformatics based
secondary metabolite profiling of genetically unique bacteria strains isolated from the
American lobster Homarus americanus. This body of work implicates potentially
important genetic pathways for both pathogenic and commensal bacteria. Furthermore,
these studies exemplify the use of next generation sequencing and biosynthetic
pathways tools to probe the potential for bacteria to produce unique natural products.
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CHAPTER 1

INTRODUCTION

1.1 Bacterial signaling and infections
Molecular signaling occurs across every known life form ensuring coordinated
behaviors for cells and organisms. In eukaryotes, chemical cues may be exchanged in
the form of hormones whereas prokaryotes are well known to utilize a phenomenon
called quorum sensing. Quorum sensing is a defined mechanism of chemical
communication facilitating coordinated behaviors akin to those of multicellular
organisms (1).
In bacteria, cell-cell communication facilitates key processes such as
bioluminescence, the secretion of virulence factors key for disease states, production
of secondary metabolites, reduction of metabolic activity and the formation of
biofilms (2-4). All of these are energetically costly and ineffective strategies for an
individual cell, but become extremely advantageous when undertaken by a population.
How individuals correctly interpret the blend of signals in their vicinity to
appropriately regulate their gene expression is crucial to their survival and success.
Chemical relationships between all organisms have been co-evolving over
billions of years. As bacteria move through their environments, they also encounter
1

and respond to complex mixtures of molecules produced by other organisms including
competitors. These foreign compounds can also influence gene expression or have
toxic consequences. Many of these molecules secreted by bacteria can act on diverse
cell types, even altering cell functions of eukaryotic cells (5). These inter-kingdom
communications mediate symbiotic and pathogenic relationships between bacteria and
their animal and plant hosts (6). Understanding the roles that specific compounds play
in natural environments can inform new ways of controlling bacterial populations,
especially for infections. This dissertation aims to expand our understanding of
chemical signaling to facilitate new treatment strategies for bacterial infections.

1.2 Quorum sensing, N-acyl homoserine lactones and quiescence
Quorum sensing is the underlying communication pathway that controls density
dependent decision-making in prokaryotes. Individual cells produce and excrete signal
molecules that can be detected by their kin. The concentration of these signal
molecules, referred to as autoinducers, increases until a receptor response is initiated
within the population (2). Hence, this phenomenon relies upon the abundance of
extracellular compounds as a proxy for cell abundance, and enables coordinated,
multi-cellular behaviors by bacteria.
One of the largest classes of autoinducers are N-acyl homoserine lactones
(AHLs). These molecules are produced prolifically across phylogenetically-diverse
2

Gram-negative bacteria and are able to freely diffuse across bacterial membranes
making them ideal cell-cell signaling molecules. When AHLs accumulate above the
required threshold, the autoinducers bind to a receptor and trigger a signaling cascade
that results in population-wide alterations in gene expression (7). Quorum sensing has
been shown to control virulence factor production and biofilm formation during
infections (2). Virulence factors often trigger the signs of infection in the host
organism. While AHLs have been extensively studied in Gram-negative bacteria, the
chemical diversity of quorum sensing signals remains unknown. Understanding the
identity and roles of autoinducers is important for finding new strategies and
treatments for bacterial infections (8).
In Chapter 2 of this dissertation, I explored the use of peptidoglycan fragments as
chemical signals to reverse dormant phenotypes in uropathogenic Escherichia coli
(UPEC). Some pathogens, including E. coli, rely upon dormant (i.e. nonproliferating) states to persist within hosts. Growing cells release ~7% peptidoglycan
(PG) fragments from their cell wall during exponential growth (9). These fragments
have been shown to be key signals for reversing dormancy in Bacillus and
Mycobacterium (2,10). Hence, certain PG fragments may serve as quorum signals to
indicate favorable conditions and exit this state, leading to recurrent infections of the
host (11).

3

The mechanisms and requirements for dormancy (i.e. quiescence) in UPEC and
the sensing molecules that reverse this phenotype are now becoming better
understood. UPEC cells are able to adhere to human bladder epithelial cells, where
they are internalized to form intracellular bacteria communities (IBCs). Once
internalized, UPEC cells enter into a quiescent state, during which they evade both
host immune response and antibiotic treatment (12). The phenomenon of quiescence
has been reported for several bacteria including Bacillus spp., Bordetella pertusis, and
E. coli (3,12). For certain UPEC, the quiescent state can be reliably simulated through
agar based nutrient limitation (12).
The archetypical peptidoglycan structure consists of a repeating disaccharides (Nacetylglucosamine and N-acetylmuramic acid) backbone covalently bonded to a stem
peptide chain containing 2-5 amino acid residues. The stem peptide structure is
predominantly L-alanine, D-glutamic acid, meso-diaminopimelic acid (mDAP) and Dalanine. The dibasic amino acid DAP forms crosslinks with adjacent strands forming
the structural rigidity of the cell wall (Figure 2). Bacterial peptidoglycan structure
variability is extensive, including modifications of both the sugar backbone and amino
acid stem peptide chain (13). For example, Staphylococcus peptidoglycan exhibits a
modification of L-lysine at the third position of the stem peptide chain (14). Most
Gram-positive bacteria contain a deacetylase, encoded by the gene pdgA, which causes
N-deacetylation of either one or both of the sugars in the backbone (14). Many studies
4

have investigated the properties of peptidoglycan fragments; however, very few have
been able to deduce the single bioactive components.
Components of peptidoglycan have been investigated for their function in
modulating developmental transitions out of non-growing, dormant cell states and for
their effects on host cells during infections. Peptidoglycan has been shown to stimulate
resuscitation and germination of Mycobacterium tuberculosis, Mycobacterium
smegmatis and Bacillus subtilis (10, 15, 16). Hosts cell interactions with
peptidoglycan fragments vary from symbiotic to pathogenic. In whooping cough, the
anhydrous disaccharide tetrapeptide of peptidoglycan (TCT) causes tracheal
cytotoxicity to human ciliated epithelial cells (17, 18). Smaller fragments of the stem
peptide structure also elicit similar dose dependent toxicity (17). The same product
from Neisseria gonorrhoeae is cytotoxic to human fallopian tube epithelial cells (19,
20). Contrastingly, Vibrio fischeri utilizes TCT to induce normal cell metamorphosis
in the light organ of bobtail squid forming a mutualistic relationship (21, 22).
Peptidoglycan-derived fragments are recognized by host immune systems and
promote defense responses against bacterial infections in mammals, invertebrates and
plants (5, 17, 23). Thus, peptidoglycan can serve as an inter-kingdom signal molecule,
modulating both prokaryotic and eukaryotic cells. Table 1 summarizes the known
functions of common peptidoglycan fragments. Interestingly, most studies are unable

5

to identify the specific PG fragments that are singly responsible for the observed
effects.
Although mostly bacterial pathogens have been studied in their ability to form a
dormant state, about 60% of the microbial biomass on Earth is thought to be quiescent
(11). These organisms may survive in the absence of nutrients for periods of up to
years. Creating robust in vitro assays to demonstrate and study quiescence are
inherently difficult, but essential for understanding the control mechanisms for
reversing these states (7). The occurrence and signaling mechanisms that facilitate the
behavior into and out of bacterial quiescence are currently understudied and represent
an important area of research for tackling recurrent bacterial infections.

1.3 Natural products and bacterial signaling
Natural products have historically served as a powerful source of novel
therapeutic agents against bacterial infections. Currently, 59% of all FDA approved
drugs to treat bacterial infections originated from natural products produced by
microorganisms (24). Traditionally these molecules are isolated and tested as pure
compounds in bioassays. However, in natural environments many signals are being
produced concurrently and may work cooperatively. This creates a complex interplay
that is likely important for microbial competition and disease progression but poorly
understood. Replicating the ‘cocktails’ of compounds used in nature represents an
6

untapped opportunity to design of new therapeutic drugs and drug combinations. This
is especially true as new knowledge emerges regarding phenotypes that influence drug
resistance and genomic technologies enable more rapid discovery of novel natural
products skeletons.
Vibrio spp. are ubiquitous in marine ecosystems and prolific pathogens. For
example, V. parahaemolyticus is the leading cause of seafood-borne illness in the
United States (29), causing gastroenteritis that often requires treatment with
antibiotics. Natural products produced by marine bacteria may offer novel ways of
tackling the prevalence of this bacterium in seafood. Swarming motility is one
phenotype that increases antibiotic resistance and speed of infection on solid or semisolid surfaces such as tissues (25, 26). Bacterial swarming is induced by quorum
sensing, alterations in ion channel fluxes, and iron scarcity (27). Swarming is enabled
by molecules that decrease surface tension, thereby allowing coordinated, directional
movement of cells (27, 28). Identification of molecules that induce or inhibit
swarming motility could lead to unconventional tools for controlling infections.
The ubiquitous Gram-positive marine bacterium Bacillus pumilus produces
structurally diverse secondary metabolites including lipopeptide, polypeptides,
macrolactones, fatty acids, polyketides and isocoumarins (30-32). As explored in
Chapter 3 of this dissertation, partnering antimicrobial activity with induction of
bacterial motility poses an unconventional and intriguing approach for controlling and
7

modulating infections. These ecological observations could unlock further research on
combinations of secondary metabolites as multifaceted treatment strategies.

1.4 Emerging techniques for understanding the roll of cell signaling molecule
bacterial diseases.
Antibiotic resistant bacterial infections pose a world health threat, causing more
than two million illnesses in the USA in 2014 (33). The increased prevalence of multidrug-resistant (MDR) pathogens has caused decreased effectiveness of front line
antibiotics. In the United States alone, 23,000 people die annually from drug-resistant
infections (34). Despite incentives from the Infectious Disease Society of America
(IDSA), approval of new antibiotics has dropped significantly in recent years and only
four novel drugs have been approved since 1998 (35). Alternative treatment options
are needed to increase the effectiveness of our current antibiotics while avoiding the
emergence of drug resistance. Such options could include compounds that modulate
crucial bacterial behaviors involved in pathogenesis.

1.4.1

Matrix-assisted laser desorption ionization-time of flight imaging mass
spectrometry (MALDI-TOF IMS)

Mass spectrometry is an analytical technique utilized to understand the chemical
diversity of the natural world. It is highly sensitive and has allowed significant
8

advances in the detection of naturally occurring molecules and measurement of their
ecologically relevant concentrations. The development of imaging mass spectrometry
(IMS) techniques has advanced this approach to include spatial mapping of ionizable
molecules on a surface. IMS is now particularly useful for probing the biological
effects induced by signaling molecules (36).
Visualizing chemical production in situ is fundamental to understanding the direct
relationships between signal molecules, allelopathic secondary metabolites and
bacterial response. Matrix-Assisted Laser Desorption Ionization-Time of flight
Imaging Mass Spectrometry (MALDI-TOF IMS) allows in situ data collection for
compounds produced by actively growing bacterial colonies on agar surfaces. This
technique involves culturing one or more bacteria on thin agar plates and applying a
uniform dry coat matrix. The matrix is generally a combination of small organic acids
that co-crystalize with the sample and facilitate ionization from laser energy. MALDITOF IMS is able to capture the metabolic exchange of information between two
bacteria grown in close proximity (37). This powerful technique can be applied to
rapidly discriminate bacterial function based on key metabolite production (38).
MADLI-TOF IMS was used in Chapter 3 of this dissertation to investigate the
chemical interplay between a marine B. pumilus and V. parahaemolyticus.

1.4.2

Genomic and computational approaches for natural product discovery
9

Advances in genomics have revealed that the majority of biosynthetic gene
clusters (BGCs) are not linked to any previously identified natural products (39). The
abundance of ‘silent’ BGCs within even well studied bacteria has identified a
bottleneck for natural product discovery (40). Genomic data also provides substantial
insights into the pool of secondary metabolites that individual bacteria strains are able
to produce. Several powerful online tools now provide structure predictions of
biosynthetic products from sequence data (41), allowing targeting of novel natural
product scaffolds from genetically unique pathways. These chemical pathways are
frequently not activated under standard laboratory conditions but may be induced
during co-culturing conditions due to competitive conditions that better mimic the
natural environment. Chapter 4 of this dissertation, includes a collection of three
manuscripts describing the genomes of marine bacteria and their expected biosynthetic
potential.

1.5 Future perspectives for bacterial disease treatment
In nature, diverse microbes are in intimate contact with each other, and cell-cell
chemical signals are exchanged within and between phylogenetically distinct
populations (42). These signals can range from simple lactones to complex peptides.
Each individual compound can alter the expression of vast numbers of genes, affecting
biological processes and bacterial infections. Interrupting these signals may block
10

virulence factors responsible for antibiotic-resistance-increasing phenotypes without
increasing MDR, thus offering possible advantages for treating bacterial infections.
Alternative treatment options for bacterial infections, including those that increase the
effectiveness of our current antibiotics, may someday significantly improve our ability
to confront drug resistance. The overall theme of my dissertation research has been to
explore how bacterial metabolites influence the behaviors and growth of two
problematic pathogens: human UPEC and the marine pathogen V. parahaemolyticus.
The aim was to reveal possible new mechanisms and tools to tackle these infectious
diseases.
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Quorum Sensing Molecules

Inter and Intra-species communication

Phenotypic Changes:
Quiescence
Swarming motility
Secondary Metabolites

Figure 1: Model of bacterial chemical communication. Chemical signals, in the form
of quorum sensing autoinducers and secondary metabolites, act as inter and intraspecies communications to facilitate phenotypic changes.
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Figure 2: The structure of peptidoglycan. A) A single muropeptide disaccharide
pentapeptide. B) The structure of peptidoglycan within the cell wall showing the
dibasic amino acid cross-link between strands that forms the structure rigidity.
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Table 1: Known chemical signaling functions of compounds from peptidoglycan.
Peptidoglycan Fragment

Structure

Disaccharide tripeptide

Producing Organism

Function

E. coli and B. subtilis

Exit from dormancy in B. subtilis
(3).

L-ala
D-glu
mDAP

O

Anhydro-disaccharide
tetrapeptide

B. pertussis

Tracheal cytotoxicity to human
ciliated cells (17).

L-ala
D-glu
mDAP

V. fischeri

D-ala

Signal for morphogenesis in the
bobtail squid (21).

N. gonorrheae

Cytotoxic to human fallopian tube
epithelial cells (19).

Disaccharide

Aeromonas spp.

pentapeptide

Beta-lactamase induction in
Aeromonas hydrophila (43).

L-ala
D-glu
mDAP
D-ala
D-ala

O

Anhydro-disaccharide
pentapeptide

Beta-lactamase induction in

E. coli

Enterobacter cloacae (44).

L-ala
D-glu
mDAP
D-ala
D-ala

Lac-tetrapeptide

D-lactate

B. pertussis

Tracheal cytotoxicity to human

L-ala

ciliated cells (17).

D-glu
mDAP
D-ala
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Tetrapeptide

L-ala

B. pertussis

D-glu

Partial tracheal cytotoxicity to
human ciliated cells (17).

mDAP
D-ala

Dipeptide

D-glu

B. subtilis/pDML995

mDAP/L-lys

Increased beta-lactam resistance in
Bacillus licheniformis (45).
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Abstract
Uropathogenic Escherichia coli (UPEC) are the leading cause of human urinary tract
infections (UTIs) and many patients experience recurrent infection after successful
antibiotic treatment. The source of recurrent infections may be persistent bacterial
reservoirs in vivo that are in a quiescent state and thus are not susceptible to
antibiotics. Here, we show that multiple UPEC strains require a quorum to proliferate
in vitro with glucose as the carbon source. At low cell density, the bacteria remain
viable but enter a quiescent, non-proliferative state. Of the clinical UPEC isolates
tested to date, 35% (51/145) enter this quiescent state, including isolates from the
recently emerged, multidrug-resistant pandemic lineage ST131 (i.e., strain JJ1886) and
isolates from the classic endemic lineage ST73 (i.e., strain CFT073). Moreover,
quorum-dependent UPEC quiescence is prevented and reversed by small molecule
proliferants that stimulate growth, including peptidoglycan (PG) stem tetra- and
pentapeptides, and the amino acids L-lysine and L-methionine. Peptidoglycan
fragments originate from the peptidoglycan layer that supports the bacterial cell wall
but are released as bacteria grow. These fragments are detected by a variety of
25

organisms, including human cells, other diverse bacteria and, as we show here for the
first time, UPEC. Together, these results show that (i) PG stem peptide sensing and
uptake of L-lysine by UPEC modulate the quorum-regulated decision to proliferate,
and (ii) UPEC quiescence can be prevented by both intra- and interspecies PG
fragment signaling.
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Introduction
At least 80% of urinary tract infections (UTIs) are caused by uropathogenic
Escherichia coli (UPEC) strains, and 27% of patients with a UTI experience
recurrence within 12 months after successful antibiotic treatment 1-3. UPEC appear to
enter a quiescent, non-growing state within urothelial transitional cells in the bladder
wall that may enable E. coli, long after antibiotic treatment has been terminated, to
resume division within bladder urine after apoptotic release from those cells 4,5.
We recently reported the discovery of a quiescent state of E. coli that is
common among UPEC strains 6. E. coli CFT073, a member of the major UPEC
lineage sequence-type (ST) 73, and approximately 80% of ST73 strains tested,
proliferate on glucose minimal agar plates seeded with 106 or more CFU, but become
quiescent on glucose minimal agar when plated at a cell density of less than 106 CFU
6. Moreover, 23% of randomly selected UPEC strains of diverse STs isolated from
community-acquired UTIs also become quiescent on glucose minimal plates seeded
with less than 106 CFU 6. Remarkably, these results indicate that growth of many
UPEC strains on glucose minimal agar is quorum-dependent 6. Alternative sole
carbon sources, including acetate, arabinose and N-acetylglucosamine (NAG), also
lead to cells entering quiescence at low plating density, whereas glycerol, ribose and
xylose support proliferation 6. We also reported that mini-Tn5 transposon insertions in
five central carbon metabolism genes (gdhA, gnd, pykF, sdhA, zwf) prevent
27

quiescence, suggesting that metabolic function must remain intact during quiescence
even though the cells are non-proliferative. CFT073 quiescence is also prevented
when cells are placed near a single colony of actively growing CFT073 or E. coli
MG1655, a K-12 laboratory strain, suggesting that the actively growing cells release
one or more molecules that act as a proliferant 6. Indeed, we showed that L-lysine is a
proliferant for quiescent CFT073 cells, but only in combination with either Lmethionine or L-tyrosine, yet CFT073 is not auxotrophic for lysine, methionine or
tyrosine, and the remaining 17 amino acids play no role in preventing CFT073
quiescence 6. Quorum-dependent proliferation suggests the ability to sense a cell-tocell signal(s). In this case the signal includes L-lysine and L-methionine, and signal
detection underlies the decision by each individual cell to grow and divide or to enter
the quiescent state. This suggests that the transition between the proliferative and
quiescent states is controlled by a quorum sensing system 7,8.

Here we show that quiescent CFT073 cells are filamentous and that L-lysine
import into quiescent CFT073 stimulates proliferation, suggesting that L-lysine
synthesis is inhibited during quiescence. In two pathogenic UPEC strains, including
CFT073, a prototypic ST73 UPEC strain, and JJ1886, a pandemic ST131 strain that
displays increased sensitivity to proliferants, we show that peptidoglycan (PG) stem
peptides prevent quiescence. PG is a component of the bacterial cell wall that contains
polymers of alternating linked sugars NAG and N-acetyl muramic acid (NAM), with
28

attached stem peptides containing D-amino acids that crosslink. PG fragments have
been reported to regulate development of Bacillus subtilis and Mycobacterium
tuberculosis 9-11. PG fragments are also normally secreted by growing E. coli 12, and
here we show for the first time that they act as quorum-signaling molecules in UPEC.
In this study we demonstrate that population-sensing and metabolite availability
modulate the quiescent state of UPEC, and we define an in vitro model system for
UPEC quiescence for further study of UPEC physiology.

Results
Quorum-dependent growth of UPEC and prevention of quiescence on glucose
minimal agar plates by secreted signals. UPEC strain CFT073 enters a quiescent
state when plated at low cell density (<106 cells per plate) on glucose minimal agar yet
grows robustly when plated at high cell density (>106 cells per plate), demonstrating
that growth of CFT073 on glucose minimal agar plates is quorum-dependent (Fig.
S1A). As reported previously, quiescent CFT073 cells can be resuscitated by
challenge with specific external stimuli, called proliferants, including 5 µl of a
solution containing L-lysine (1 mM) and L-methionine (1 mM), 5 µl of human urine,
or a single colony of actively growing E. coli spp. (CFT073 or MG1655), added to the
plate 6. In a soft agar overlay containing 104 quiescent CFT073 cells, we tested the
known proliferants and in each case observed the development of a zone of actively
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growing colonies surrounding the site of challenge (Fig. 1A). Without challenge, cells
failed to grow throughout the course of the experiment (24 h) and remained quiescent.
We also tested additional clinical isolates and found that quorum-dependent growth on
glucose minimal agar is common among the ST131 UPEC strains in this study (8/33)
(Table 1); however, we discovered that the number of cells constituting a quorum
varies among strains. For example, the ST131 strain JJ1886 was proliferative on
glucose minimal agar at a plating density greater than 103 CFU, but quiescent at or
below 103 CFU (Table 1). Of the 35 strains tested in this study, 10 were reversibly
quiescent on glucose minimal agar, and three of those strains were quiescent at or
below a plating density of 103 CFU, but non-quiescent at 105 CFU (Table 1). These
results show that sensitivity for quorum detection varies by strain, i.e., is strainspecific.

Next, we monitored the zone of growth of CFT073 cells as they exited quiescence
over 72 h. First, we poured soft agar plates containing quiescent CFT073 cells seeded
at 104 CFU per plate, placed an actively growing colony of CFT073 onto the surface
of each plate by toothpick and measured the zones of growth around the sites of
inoculation at 24, 48 and 72 h. We observed that the zone of growth expands in
diameter until the entire plate is covered by a lawn of actively growing cells (Fig. 1B
and 1C). There are two potential scenarios to explain this result. First, the
30

proliferant(s) that stimulates growth of quiescent cells is continuously released from
the toothpicked colony throughout the experiment and induces growth of distal
quiescent cells as it diffuses across the plate. Alternatively, the proliferant(s) that
stimulates growth of quiescent cells is released from the toothpicked colony but, upon
release of the signal, neighboring and formerly quiescent cells begin secreting their
own signal, thereby stimulating adjacent quiescent cells to grow. To distinguish
between these possibilities, glucose minimal agar plates were seeded with 104
quiescent CFT073 cells from a stationary phase liquid glucose minimal medium
culture, and a single CFT073 colony was toothpicked onto the center of each plate.
The plates were then incubated for 24 h. During that time, a small zone of growth
formed on each plate around the central toothpicked colony (Fig. 1B, 1C and 1D).
After the zone had formed at 24 h, the toothpicked colony was removed to stop the
colony from secreting additional signal(s). Even after removal of the toothpicked
colony from the plate, the zone of growth continued to expand, unabated, for an
additional 48 h and at a similar rate as the control plate, where the colony had been left
intact (Fig. 1C and 1D). These results suggest that the proliferation-promoting signal
propagates across the plate from CFT073 cells as they exit quiescence. These results
further show that quiescent CFT073 cells at the edge of the plate remain viable and
can be stimulated to proliferate for up to 72 h.
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Quiescent CFT073 cells are filamentous on glucose minimal agar plates. During
infection, UPEC cells from quiescent intracellular reservoirs (QIRs) display several
different morphologies, including rods, spheres and filaments 13-15. To determine if
quiescent cells in our in vitro quiescence system also display morphological features
that are distinct from actively growing cells, we compared the cell morphologies of
CFT073 cells under several culture conditions, including LB agar, and glucose
minimal agar supplemented with L-lysine (1 mM) and L-methionine (1 mM), where
indicated (Fig. 2A). After 24 h on LB agar or on glucose minimal agar supplemented
with L-lysine and L-methionine, colonies were apparent and individual cells collected
and analyzed by microscopy appeared as short rods with mean lengths of 1.72 ± 0.59
μm (n = 200) and 2.33 ± 0.80 μm (n = 200), respectively (Fig. 2A and 2B). By
contrast, after 24 h on non-supplemented glucose minimal agar plates, no colonies
were detected and quiescent cells harvested from the plate had a broad length
distribution, with a mean length of 7.17 ± 4.34 μm (n = 200), which is 300% longer
than cells grown on glucose minimal agar supplemented with lysine and methionine
(Fig. 2A and 2B). Many quiescent cells were longer than 10 μm and 16.5% of them
appeared to contain one or more incomplete septa (Fig. 2A and 2B) (Fig. S1B). To
assess for changes in cell length with extended incubation, we also measured cell
length at 0 h and 48 h after entry into quiescence. At 0 h, cells harvested from a
stationary phase culture grown in liquid glucose minimal medium were short rods with
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a mean length of 2.14 ± 0.58 μm (n = 200). After 48 h on glucose minimal agar plates,
quiescent cells were filamentous, with a mean length of 6.84 ± 3.76 μm (n = 72),
which is similar to the mean length at 24 h (Fig. S1B and S1C). These results suggest
that quiescent CFT073 cells elongate during the first 24 h on the plate but fail to
complete division.

Lysine import is necessary for lysine to prevent quiescence, but an additional
signal that induces proliferation is released from actively growing cells. L-lysine is
a proliferant for quiescent CFT073 cells on glucose minimal agar in the presence of Lmethionine 6. To determine whether L-lysine must be imported into CFT073 cells to
prevent quiescence, we constructed a CFT073 lysP insertion-deletion mutant by λ-Red
recombination (Table S1). Of the three known lysine importers in E. coli, LysP is the
major importer and a member of the amino acid, polyamine and organocation (APC)
family of transporters 16,17_ENREF_9. CFT073 ∆lysP cells grew well overnight in
liquid glucose minimal medium, similar to the wild type CFT073 strain (Fig. S2A)
and exhibited quiescence on glucose minimal agar at low cell density (104 cells per
plate) (Fig. 3); yet, it grew robustly when plated at high density (108 cells per plate).
Unlike wildtype CFT073, when 5 µl of a solution of L-lysine (1 mM) and Lmethionine (1 mM) was added to quiescent CFT073 ∆lysP cells plated at 104 CFU, no
colony growth was observed after 24 h of incubation, suggesting that LysP-dependent
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transport is critical for lysine to stimulate proliferation. This also suggests that lysine
biosynthesis is inhibited in quiescent cells. CFT073 ∆lysP was complemented with a
plasmid containing lysP (pLysP), which restored the ability of the strain to proliferate
upon addition of L-lysine in the presence of L-methionine at low cell density (Fig. 3).
Although quiescent CFT073 ∆lysP cells failed to respond to L-lysine, they proliferated
after a colony of actively growing CFT073 cells was added to the plate (Fig. 3).
Collectively, these results suggest that import of L-lysine is required for L-lysine to
stimulate proliferation and override the absence of the quorum, and that one or more
L-lysine-independent proliferants that reverse quiescence are secreted from bacterial
colonies.

ArgP is a transcriptional regulator of lysP 16,18. In the absence of lysine, ArgP
positively regulates transcription of lysP, along with several E. coli genes involved in
lysine and PG biosynthesis, including dapB (dihydropicolinate reductase), dapD
(tetrahydrodipicolinate succinylase), lysA (diaminopimelate decarboxylase) and lysC
(aspartokinase III) 16,18-20. To test whether ArgP plays a regulatory role in quorumdependent growth or quiescence, we deleted argP. Like wild type CFT073, CFT073
ΔargP cells grew well overnight in liquid glucose minimal medium (Fig. S2A) and
were quiescent at low cell density (104 CFU per plate) on glucose minimal agar (Fig.
3), indicating that ArgP is not essential for inducing quiescence at low density (Fig. 3).
34

Similar to the result with CFT073 ∆lysP cells, quiescent CFT073 ΔargP cells failed to
respond to the addition of L-lysine with L-methionine after 24 h of incubation, but the
cells proliferated in response to a colony of CFT073 toothpicked to the center of a
glucose minimal agar plate seeded with 104 CFU of CFT073 ΔargP (Fig. 3).
Complementation of CFT073 ∆argP with the wildtype CFT073 argP gene on a
plasmid (pArgP) restored the ability of the strain to respond to L-lysine in the presence
of L-methionine at low cell density (Fig. 3). Since LysP expression has been reported
to be repressed 35-fold in E. coli argP mutants 20, this result both (i) supports the
conclusion that external L-lysine must be transported into CFT073 via LysP in order
to prevent quiescence and (ii) confirms that expression of LysP is regulated by ArgP.
Together, these results also show that there is a molecule(s) other than L-lysine
secreted by actively growing cells that stimulates proliferation of quiescent CFT073
cells.

To further clarify why the population threshold that defines a quorum varies between
strains, we investigated the ST131 clinical isolate JJ1886, which exhibits quiescence
on glucose minimal agar at or below a plating density of 103 CFU, but grows robustly
on such plates at 105 CFU and in liquid glucose minimal medium (Fig. 4A and S2B).
We observed that 5 µl of a solution of L-lysine (1 mM) alone is sufficient to promote
growth and prevent quiescence of JJ1886 plated at low density on glucose minimal
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agar (103 CFU per plate), although growth is more efficient in the presence of Lmethionine (1 mM), and L-methionine (1 mM) alone does not stimulate growth (Fig.
4B). Since quiescent JJ1886 cells on glucose minimal agar proliferate in the presence
of L-lysine alone, we titrated the L-lysine concentration to determine the threshold for
stimulation of growth and compared JJ1886 to CFT073. We determined that a low
concentration of L-lysine (5 µl of 0.1 mM) is sufficient to promote proliferation of
quiescent JJ1886 cells (103 CFU/plate), whereas quiescent CFT073 cells (103
CFU/plate) proliferated at a higher concentration of L-lysine (>0.5 mM) and only in
the presence of L-methionine. These results suggest that although JJ1886 behaves
phenotypically similar to CFT073 with respect to quiescence, it is more sensitive to
detecting or responding to an external signal(s) that prevents quiescence. We then
tested if quiescent JJ1886 also responds to the other known CFT073 proliferants,
including 5 µl of urine or a colony of actively growing E. coli cells, and observed that
both agents were effective for stimulating proliferation of quiescent JJ1886 cells (Fig.
4B).

Since L-lysine stimulates proliferation of both JJ1886 and CFT073, we tested 5 µl of
D-lysine (1 mM) and 5 µl of the biosynthetic lysine precursor diaminopimelic acid
(Dap) (1 mM) for stimulating proliferation of quiescent cells. Both agents failed to
stimulate growth of quiescent CFT073 and JJ1886 (Fig. S3A and S3B).
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Peptidoglycan fragments prevent UPEC quiescence. Next, we considered PG as a
potential signal that would communicate a quorum since PG fragments, including di-,
tri-, and tetrapeptides, are normally secreted by actively growing bacterial cells
including E. coli 10,12,21,22. We tested if peptidoglycan fragments from E. coli could
prevent quiescence and stimulate proliferation of CFT073 and JJ1886. Peptidoglycan
was digested with mutanolysin, a mixture of two N-acetylmuramidases and an Nacetylmuramyl-L-alanine

amidase,

to

release

a

heterogeneous

mixture

of

peptidoglycan fragments, including various muropeptides and stem peptides (Fig. 5A).
Addition of the total mixture of digested peptidoglycan fragments from E. coli induced
proliferation of quiescent JJ1886 cells, plated at 103 CFU per plate (Fig. 5A), and
quiescent CFT073 cells, plated at 104 CFU per plate (Fig. S4A). Titrating the amount
of total peptidoglycan added to the agar plate revealed a dose-dependent response,
leading to differences in the zones of growth around the site of addition (Fig. S4B).
Digested peptidoglycan from B. subtilis and Staphylococcus aureus also stimulated
proliferation of quiescent JJ1886 and CFT073 cells (Fig. S4C and S4D). Furthermore,
peptidoglycan fragments were also effective for stimulating proliferation of quiescent
CFT073 lysP cells to proliferate, indicating that the peptidoglycan response is
independent of lysine import (Fig. S5A).

Interestingly, these results show that

quiescent E. coli cells respond to PG fragments from various bacterial species, which
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can differ in the identity of the amino acid at the third position of the stem peptide,
usually meso-Dap (i.e., E. coli) or L-lysine (i.e., S. aureus) 10,23,24.

Peptidoglycan stem peptides act as signals to promote proliferation of quiescent
JJ1886 and CFT073 cells. To identify which fragment(s) of digested PG stimulates
proliferation

of

quiescent

cells,

we

performed

high

performance

liquid

chromatography-mass spectrometry (HPLC-MS) on E. coli PG fragment mixtures
(Fig. 5A) and tested fractions across the elution for the ability to promote proliferation
of quiescent JJ1886 cells. We found that early fractions that were collected with
retention times up to 10 min were sufficient to stimulate proliferation of quiescent
JJ1886 cells (Fig. S5B). Tandem mass spectrometry confirmed that these fractions
contain low molecular weight peptidoglycan fragments, consistent with stem peptides,
such as the tri- and tetrapeptides. In contrast, later eluting fractions containing
muropeptides did not stimulate proliferation of quiescent JJ1886 cells (Fig. S5B).

To further explore the molecular determinants of PG peptides that stimulate
proliferation of quiescent cells, we compared several high-purity stem peptide
fragments of varying amino acid compositions and lengths. We observed that a
tripeptide, representing the minimal unit of an E. coli peptidoglycan stem peptide that
could be generated from amidase and carboxypeptidase activities in the E. coli
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periplasm (L-Ala-D-Glu-mDap), failed to stimulate proliferation of quiescent JJ1886
cells (Fig. 5B). However, a peptidoglycan pentapeptide, L-Ala-D-Glu-L-Lys-D-AlaD-Ala (A-E-K-A-A), similar to the stem pentapeptide present in S. aureus
peptidoglycan, stimulated proliferation of quiescent JJ1886 (Fig. 5C) and CFT073
(Fig. S5A) cells. We also tested a smaller fragment of the pentapeptide, acetyl-L-LysD-Ala-D-Ala (K-A-A) but did not observe stimulatory activity (Fig. S6A). Fragments
including the disaccharide moiety alone, containing NAG and NAM (NAG-NAM)
(Fig. 5D), and higher molecular weight molecules with the attached stem peptide (i.e.,
disaccharide tetrapeptide) (Fig. 5E), in various states of crosslinking, eluted later, after
10 min (Fig. S7), and had no proliferant activity. NAG-NAG, NAG and NAM were
also tested, but none of these sugars stimulated proliferation of quiescent cells (Fig.
S6B).

To determine if a peptidoglycan stem peptide longer than three amino acids and
derived from E. coli stimulates proliferation of quiescent cells, we generated
tetrapeptide in situ by digesting purified disaccharide tetrapeptide (isolated by HPLC)
with AmiD, an amidase from E. coli 22. AmiD cleaves a stem peptide from attached
sugars (Fig. S8A). After cleavage to release the tetrapeptide, the reaction products
were highly active for stimulating proliferation of both quiescent JJ1886 cells (Fig.
5F) (Fig. S8B) and quiescent CFT073 cells (Fig. S8C). NAG-NAM displays no
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activity alone, therefore these results suggest that peptidoglycan stem peptides from E.
coli (tetrapeptide) and S. aureus (pentapeptide) function as proliferants.

Finally, to further clarify if stem peptides exert their function without entering the
cytoplasm or if they are imported into a quiescent cell and then enter the
peptidoglycan recycling pathway, we constructed JJ1886 strains deleted for the
oligopeptide transporter operon, oppABCDF 25-29, and also the peptidoglycan
tripeptide-specific delivery protein mppA 27,30-32. Both deletion strains grew well in
liquid glucose minimal medium and became quiescent when plated at 103 CFU per
plate, similar to parent strain JJ1886; furthermore, like JJ886, both strains were
stimulated to proliferate by addition of stem peptides to the plate (Fig. S8B and S8D),
indicating that it is not necessary for the stem peptides to enter the cytoplasm via the
Opp transporter in order to act as a signal to overcome quiescence.

Discussion
Here, we show that two virulent UPEC strains, CFT073 and JJ1886, enter a quiescent
state when plated on glucose minimal agar, and this state is prevented and reversed by
proliferants, including peptidoglycan stem peptides consisting of four (e.g., E. coli) or
five (e.g., S. aureus) amino acids. Quiescence is a unique physiological state described
for E. coli that is common among UPEC strains (i.e., 51/145 isolates tested) and is
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quorum-regulated. The quiescent state is adopted by an entire population of cells
under a given growth condition, in contrast to a persister state, which occurs in a small
percentage of cells within a population 33-37. Adoption of a quiescent, nonproliferative state would require many physiological systems to slow (e.g.,
transcription, translation) or stop (e.g., DNA replication, division and peptidoglycan
synthesis). Accordingly, we observed that quiescent cells adopt a filamentous
morphology, failing to successfully divide or proliferate despite extended incubation
(Fig. S1B). Finally, different strains respond to known proliferants with varying
sensitivities, suggesting that either the sensitivity of detection or the regulatory control
over physiological pathways varies among strains. For example, L-lysine is sufficient
to induce proliferation of quiescent JJ1886 cells (Fig. 4B), whereas L-lysine must be
supplemented with either L-methionine or L-tyrosine to induce proliferation of
quiescent CFT073 cells 6. While lysine import is one way to overcome quiescence,
stimulation by peptidoglycan stem peptides occurs independently of the lysine
importer lysP, suggesting that there are multiple regulatory inputs that enable
reinitiation of the cell cycle. It is also possible that detection of peptidoglycan
fragments stimulates lysine biosynthesis or increases intracellular lysine concentration
in a coordinated manner, which then induces proliferation.

Muropeptide fragments are known to resuscitate dormant Mycobacterium smegmatis
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38 and to signal B. subtilis endospores to germinate 11. Here we showed that in E.
coli, PG stem tetra- and pentapeptide fragments not only cause cells to reenter the cell
cycle, but may also act as a signal to communicate the presence of a quorum,
independent from uptake by the Opp import system. Previously, it was shown that an
oppA mutant is far less infective in a mouse UTI model than the wildtype 39, and it
was suggested that small oligopeptides, present in high concentration in urine 39, are
imported and serve as major nutrients for CFT073 growth in urine 39. Here, neither
the pentapeptide nor the tetrapeptide entered the quiescent cells via Opp, suggesting
that they are imported by a second, presently unknown, oligopeptide permease, or act
as signals in the periplasm and are recognized by a membrane receptor or signal
transduction system that, when activated, promotes cell proliferation. The
serine/threonine kinase PknB is a widely conserved PG binding protein that is
important for germination of spores in B. subtilis 11; however, no similar proteins
have been found thus far in E. coli.

The cause(s) of recurrent UTIs are complex 40; however, it appears that UPEC can
bind to, enter, and replicate within superficial facet cells in the mouse and human
bladder epithelium, resulting in intracellular biofilm-like communities (IBCs) 40,41.
IBCs escape from infected superficial facet cells within hours of development and
several cycles of IBC formation occur, but each successive round is associated with a
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reduced replication rate and smaller IBCs 15. The infected superficial facet cells
exfoliate, exposing underlying transitional epithelial cells that become infected with
IBC-derived UPEC progeny. Upon infection of transitional cells, small numbers of
UPEC appear to enter a latent or quiescent intracellular state in endosomal vesicles (2
to 12 cells/vesicle), establishing QIRs 42 that are resistant to antibiotic treatment and
are a possible cause of recurrent UPEC infection.

If the physiology of UPEC

quiescence in vitro is similar to that in vivo, understanding how PG stem peptides
prevent in vitro quiescence at the molecular level may help inform how to prevent
recurrent UPEC infections in humans.

Methods

Bacterial strains, plasmids and growth conditions. E. coli strains and plasmids used
in this study are listed in Table 1. Clinical UPEC isolates were obtained from the
collections of J. Johnson (29 strains) and E. Sokurenko (5 strains) (Table 2). Lennox
broth (LB) supplemented with agar (LB agar) was used for routine cultivation. Liquid
glucose (0.2% or 0.4%, where indicated) M9 minimal medium and 0.2% glucose M9
minimal agar plates were prepared as described previously 6. Gene deletions were
constructed by λ-Red recombination as described in Datsenko and Wanner and
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confirmed by sequencing 43. Culture density was monitored by growing cells in liquid
0.2% glucose M9 minimal medium and measuring OD600 at the indicated times.

Plasmids for complementation of both CFT073 ∆lysP and CFT073 ∆argP gene
deletions were constructed using expression vector pBAD24. Both genes were
amplified from CFT073 by whole colony PCR (lysP, 5’
atcaagaattcacatgggttccgaaactaaaactacagaag 3’, 5’
tagataagcttttatttcttatcgttctgcgggaacttc 3’; argP, 5’
atcaagaattcacatgcaacccgacacaaaattgtgtcatag 3’, 5’
tagataagcttttaatcctgacgaagaactttgtgaccataatcg 3’). The resulting PCR products were
digested with EcoRI and HindIII. Digested PCR products were ligated into
EcoRI/HindIII-digested pBad24. Both pLysP and pArgP plasmid constructs were
verified by sequencing and then transformed into either CFT073 ∆lysP or CFT073
∆argP deletion strains by electroporation. To test for complementation, transformants
were grown overnight in 0.4% glucose M9 minimal medium with ampicillin (50 μg
ml-1) and were assayed for quiescence on 0.2% glucose minimal agar supplemented
with arabinose (0.1%), where indicated.

Quiescence assay. Quiescence assays were performed as described previously 6.
CFT073 and JJ1886 wild type and mutant strains were grown on LB agar plates
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overnight at 37 °C. An isolated colony was used to inoculate 5 ml of 0.4% glucose M9
minimal medium, incubated at 37 °C with shaking overnight, and then diluted to
between 103 to 108 CFU, as indicated, in 3 ml 0.2% glucose M9 minimal medium
containing 0.75% Difco noble agar held at 45 °C. Inoculated soft agar was
immediately poured onto plates containing a 12 ml layer of 0.2% glucose M9 minimal
medium with 1.5% noble agar or directly into an 8.5 cm2 polystyrene culture dish.
Putative proliferants, including actively growing cells, amino acids, Dap (2,6diaminopimelic acid), sterile human urine and peptidoglycan fragments, were added
and plates were incubated at 37 °C for 24 to 72 h, where indicated, and then imaged.

Microscopy. Overnight cultures of CFT073 were grown to stationary phase in 0.4%
glucose M9 minimal medium. Five µl of a 3-log diluted culture was spotted onto LB
agar or 0.2% glucose M9 minimal medium with 1.5% noble agar and, where indicated,
supplemented with L-lysine (1 mM) and L-methionine (1 mM), then allowed to dry
for 1 h at room temperature. Plates were incubated at 37 °C for 24 or 48 h. Cells were
harvested onto a glass cover slip, resuspended in phosphate-buffered saline (PBS) with
ethylenediaminetetraacetic acid (EDTA) (1 mM) and applied to an agar gel pad
containing 0.2% glucose M9 minimal medium with 0.5% noble agar. Cells were
visualized by differential interference contrast (DIC) microscopy using a Zeiss LSM
700, and images were captured on an AxioCam HRc high-resolution camera with ZEN
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2012 software. Images were processed using Adobe Photoshop CC and analyzed using
NIH ImageJ software.

Peptidoglycan fragment separation. E. coli CFT073 was inoculated in 10 ml of M9
minimal medium containing 0.4% glucose and incubated at 37 °C shaking (200 rpm)
for 24 h. Cultures were subsequently inoculated into one liter of M9 minimal medium
containing 0.4% glucose and incubated for 24 h shaking (175 rpm). Methods used for
PG isolation were adapted from Desmarais et al., 2014 44. Cells were harvested at
5,000 x g for 10 min at room temperature and pellets were resuspended in 3 ml of M9
minimal medium. Cell suspensions were transferred into 6 ml of 6% sodium dodecyl
sulfate (SDS) and boiled for 3 h with stirring. After 3 h, heat was discontinued, and
cell suspensions were stirred overnight at room temperature. Cell suspensions were
centrifuged at 262,000 x g for 30 min, pellets were resuspended in liquid
chromatography mass spectrometry (LCMS) grade water and further centrifugation
and wash steps occurred until no SDS remained. The final pellet was resuspended in
900 μl of 10 mM Tris-HCl with 0.06% w/v NaCl and 100 g of Pronase E was added
to the cell suspension and then incubated for 2 h at 60 °C. After incubation, 200 μl of
6% SDS was added and the mixture was boiled at 100 °C for 30 min. Samples were
centrifuged at 262,000 x g for 30 min and washed 4 times with LCMS grade water.
The final pellet was resuspended in 200 μl of PBS and incubated with 200 U of
46

mutanolysin (Sigma-Aldrich) at 37 °C overnight. Samples were centrifuged at 16,000
x g for 10 min to remove cellular debris, PG supernatant was collected for further
testing. Mutanolysin was removed by ultrafiltration using a polyethersulfone filter
with a 3-kDa molecular weight cut-off.

Analytical high-performance liquid chromatography (HPLC) was used to purify the
PG extract. HPLC experiments were performed on a Shimadzu prominence-I LC2030C equipped with a PDA detector model LC-2030/2040, pump LC-2030, and
autosampler LC-2030. Preparative HPLC experiments were completed with a Waters
XBridge Analytical C18 5 μm, 4.6 × 250 mm column at 30 °C using a solvent gradient
of 10-100% B (5 mM ammonium acetate with 15% acetonitrile pH 4.89) run over 16
min against solvent A (5 mM ammonium acetate pH 4.37). Solvent B was held at 10%
for 4 min prior to the gradient and 100% B was held for a subsequent 4 min at the
conclusion of the method. Individual peaks were collected according to 205 nm
absorbance values at 205 nm. Initial chemical characterization was carried out by
liquid chromatography mass spectrometry (LCMS) on a Thermo Fisher ISQ EC
coupled to a Shimadzu Prominence-i LC-2030 system. Chemical separation utilized
the same mobile phase gradient as previously with a reduced flow rate of 0.6 ml min-1.
Chemical characterization of pure compounds was undertaken using electrospray

47

ionization mass spectrometry (ESIMS) using an AB Sciex TripleTOF 4600
spectrometer and LCMS/MS experiments.

Methods of LCMS/MS were performed on a AB Sciex TripleTOF 5600 spectrometer
coupled to a Waters H class UPLC. Methods of LC mirrored that of initial screening
with an adjusted flow rate of 0.5 ml min-1 on an XBridge Analytical C18 5 μm, 4.6 ×
250 mm column. Acquisition (SWATH) was performed in positive ionization mode.
The method specific parameters were as follows: gas 1 (GS1) 55 psi, gas 2 (GS2) 60
psi, curtain gas (CUR) 25 psi. The source-specific parameters were: temperature
(TEM) 500 °C, ion spray voltage floating (ISVF) 5500 V, declustering potential (DP):
100, collision energy (CE) 10 and collision energy spread (CES) 15. An initial timeof-flight (TOF) scan was collected from m/z 100 to 1500 and SWATH data was
acquired (m/z 200-1100) over 36 SWATH windows per cycles with a window size of
m/z 25 and a m/z 1 overlap between windows.

Peptidoglycan from B. subtilis (Sigma-Aldrich) or S. aureus (Sigma-Aldrich) (10 mg
ml-1) was incubated with 200 U of mutanolysin at 37 °C overnight. Peptidoglycanderived stem peptide fragments including ‘A-E-K-A-A’ pentapeptide (L-Ala-D-GluL-Lys-D-Ala-D-Ala (Sigma-Aldrich), ‘K-A-A’ tripeptide (acetyl-L-Lys-D-Ala-D-Ala)
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(Sigma-Aldrich) and ‘A-E-Dap’ tripeptide (L-Ala-D-Glu-mDap) (AnaSpec), were
each tested at 5 μl (2 mM) against strains JJ1886, JJ1886 ∆oppABCDF and JJ1886
∆mppA (103) after growth on M9 minimal agar with 0.2% glucose for 24 h at 37 °C.

Amidase cleavage of disaccharide tetrapeptide. The amiD gene sequence coding for
residues 18 through 276 was amplified from E. coli MG1655, cloned into pET-24b
using NdeI/HindIII restriction sites to incorporate a C-terminal hexahistidine tag (5’
actgacatatggcaggcgaaaaaggcat 3’, 5’ gcagtaagcttatcctgcccgtatttc 3’) and expressed in
BL21 (λde3). This resulted in removal of the N-terminal signal sequence and lipid
modification site. The cells were grown in LB supplemented with 50 μg ml-1
kanamycin at 37 °C to an OD600 of 0.8. Expression was induced with isopropyl-β-Dthiogalactoside (1 mM) for 3 h at 30 °C. Cells were harvested by centrifugation at
6,000 x g for 30 min at 4 °C and resuspended in 25 ml of 25 mM Tris-HCl (pH 7.8)
buffer containing 150 mM NaCl, 1 mM MgCl2 and 10% glycerol. Cells were lysed by
French press. Soluble cell extracts were collected by centrifugation at 30,000 x g for
30 min at 4 °C, then applied to TALON Superflow resin (GE Healthcare), washed
with 10 column volumes of lysis buffer and eluted with an imidazole gradient. Buffer
was exchanged by PD-10 desalting column to remove imidazole. Isolated E. coli PG
disaccharide tetrapeptide was digested with 315 ng of AmiD in 8.5 mM Tris-HCl (pH
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7.8), 50 mM NaCl, 0.3 mM MgCl2 and 3% glycerol for 26 h at 37 °C. Cleavage was
confirmed by LCMS analysis as described above.
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TABLE 1. Prevalence of quiescence among UPEC ST131 isolates
Strain

CFT073
Nissle 1917
JJ1886
JJ1887
JJ2547
JJ2050
JJ2528
MVAST0036
MVAST014
H17
JJ1901
JJ2087
JJ1999
MVAST167
MVAST020
JJ2134
JJ2183
JJ2489
QUC02
JJ2118
JJ2193
JJ2210
JJ2578
JJ2608
MVAST038
MVAST046
MVAST077
MVAST084
MVAST131
MVAST158
MVAST179
JJ2546
JJ2548
JJ2963
JJ2974

Sequence type

ST131
Clade

ST73
ST73
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131
ST131

n/a
n/a
H30Rx/ C2
H30Rx/ C2
H30Rx/ C2
H30R1/ C1
H30R1/ C1
H30R1/ C1
H22/ B0
H22/ B
H22/ B
H41/ A
H41/ A
H30Rx/ C2
H30Rx/ C2
H30Rx/ C2
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1
H30R1/ C1

a

Quiescent at 103 CFU Source,
and reversed by
reference
Lys and Met a
+b
6
+b
6
+c
+c
+c
+b
+
+b
+b
+b

J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
J. Johnson
E. Sokurenko
E. Sokurenko
E. Sokurenko
E. Sokurenko

Strains were seeded at 103 CFU and 105 CFU on 0.2% glucose M9 minimal agar
plates and incubated at 37 °C for 24 h, (+) represents quiescent, (-) represents nonquiescent.
b
Denotes strains that are quiescent when seeded at both 103 CFU and 105 CFU on
0.2% glucose M9 minimal agar and grown at 37 °C for 24 h.
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c

Denotes strains that are quiescent when seeded at 103 CFU, but non-quiescent when
seeded at 105 CFU on 0.2% glucose M9 minimal agar plates and grown at 37 °C for 24
h.
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Figures
No Stimulant

L-Lys + L-Met

Urine

CFT073

104 CFT073

A

B

0h

24 h

48 h

72 h

C

D

0h

24 h

72 h

48 h

Diameter of Growth
Zone (cm)

10.0

Proliferant

5.0
No
proliferant

0.0
0

24 48
Time (h)

72

Fig. 1. The quorum-regulated quiescent state of E. coli CFT073 cells on glucose
M9 minimal agar is reversible. (A) CFT073 cells (104 CFU) were plated onto M9
minimal agar with 0.2% glucose. A 5 μl solution of L-lysine (1 mM) and Lmethionine (1 mM), sterile human urine, or an actively growing colony of CFT073
was transferred to the center of the plate, cells were incubated for 24 h at 37 °C, and
the zone of growth surrounding the challenge site was monitored. (B, C) Zones of
growth expand with time after addition of an actively growing colony of CFT073 up
to 72 h. (D) Removal of the actively growing colony at 24 h has no effect on zonal
expansion. White arrows indicate position of stimulant addition, brackets indicate the
zone of colony growth and scale bars are 1 cm in length.
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LB agar
Colony growth

Glucose minimal agar
L-Lys + L-Met
No Supplement
Colony growth
No colony growth (quiescent)

B

50
Cell Length (µm)

A

40
30
20
10
0

L-Lys
No
+
Supplement
L-Met
Glucose minimal

LB

Fig. 2. Quiescent CFT073 cells are filamentous at 24 h. (A) CFT073 cells were
grown on LB agar or 0.2% glucose minimal agar at 37 °C with and without L-lysine
(1 mM) and L-methionine (1 mM), harvested at 24 h and visualized by DIC
microscopy. Scale bars are 5 μm in length. (B) Violin plot representing cell length
distribution at 24 h for 200 cells grown under conditions described in (A).
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CFT073

CFT073 ∆lysP::kan
No vector

pLysP

CFT073 ∆argP::cat
pBad24

No vector

pArgP

pBad24

CFT073

Urine

L-Lys + L-Met

No vector

Fig. 3. Quiescent CFT073 ∆lysP and ∆argP cells fail to proliferate with L-lysine.
All strains, including CFT073, CFT073 ∆lysP, CFT073 ∆argP, were plated on M9
minimal agar with 0.2% glucose at 104 CFU and then challenged with a 5 μl solution
of L-lysine (1 mM) and L-methionine (1 mM), sterile human urine or an actively
growing colony of MG1655 transferred to the center of the plate. CFT073 ∆lysP cells
containing pLysP or pBad24, where indicated, were supplemented with 50 μg ml-1
ampicillin and 0.1% arabinose. CFT073 ∆argP cells containing pArgP or pBad24,
where indicated, were supplemented with 50 μg ml-1 ampicillin. Plates were incubated
at 37°C for 24 h.
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103 JJ1886

B

No Stimulant

L-Lys + L-Met

L-Lys

L-Met

Urine

CFT073

103 JJ1886

105 JJ1886

103 JJ1886

LB

M9 + glucose

A

Fig. 4. ST131 strain JJ1886 displays quorum dependent growth. (A) JJ1886 cells
were plated onto 0.2% glucose M9 minimal agar with and LB agar at 105 and 103
CFU. JJ1886 displays quorum dependent growth at 103 CFU on glucose M9 minimal
agar. (B) JJ1886 (103 CFU) were plated onto 0.2% glucose M9 minimal agar. A 5 μl
solution of L-lysine (1 mM) and L-methionine (1 mM), L-lysine (1 mM), Lmethionine (1 mM), sterile human urine, or an actively growing colony of CFT073
was transferred onto a JJ1886-seeded plate and plates were incubated for 24 h at 37
°C.
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Fig. 5. Peptidoglycan fragments promote proliferation of quiescent JJ1886 cells.
High resolution LCMS total ion counts (TIC) including (A) mutanolysin-digested
crude E. coli PG, which was tested for stimulating proliferation of quiescent JJ1886
cells plated at 103 CFU on 0.2% glucose M9 minimal agar, inset; (B) elution of a PG
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tripeptide (L-Ala-D-Glu-mDAP), [M+H]+ 391.632 (m/z), similar to an E. coli
fragment and corresponding test for quiescence reversal, inset; (C) elution of a PG
pentapeptide (L-Ala-D-Glu-L-Lys-D-Ala-D-Ala), [M+H]+ 489.380 (m/z), identical to
a S. aureus PG pentapeptide and corresponding test for quiescence reversal, inset; (D)
elution of a NAG-NAM disaccharide, [M+K]+ 535.128 (m/z), and corresponding test
for quiescence reversal, inset; and (E) elution of a disaccharide tetrapeptide, [M+H]+
940.573 (m/z), isolated from crude E. coli PG and corresponding test for quiescence
reversal, inset; (F) products of the enzymatic reaction of E. coli-derived disaccharide
tetrapeptide isolated from HPLC and then digested with AmiD to produce tetrapeptide
(L-Ala-D-Glu-mDAP-D-Ala), [M+H]+ 462.198 (m/z), and corresponding test of
reaction products for quiescence reversal, inset. Candidate proliferants were collected
and tested in the quiescence assay as described in Methods and plates were incubated
at 37 °C for up to 24 h. Where shown, white arrows indicate position of proliferant
addition. Scale bar is 1 cm in length.
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TABLE S1. E. coli strains and plasmids used for genetic analyses and
constructions in this study
E. coli
Genotype
Strain or Plasmid
Strains
Spontaneous streptomycinCFT073 Strr
resistant mutant of CFT073
MG1655
LAM-rph-1
BL21 (λde3)
F- ompT gal dcm lon hsdSB(rBmB-) λ(de3[lacI lacUV5-T7 gene
1 ind1 sam7 nin5])
ED0052
CFT073 Strr ∆lysP::parE-kan
ED0070

CFT073 Strr ∆argP::cat

JJ1886
ED0118

JJ1886 ∆mppA::cat

ED0131

JJ1886 ∆oppABCDF::cat

Plasmids
pKD46
pKD3
pKD267
pKD119
pBAD24
pLysP
pArgP
pet-AmiD

a

Identifier

Source, reference
or construction

CFT073

6

MG1655

45
EMD Millipore,
USA

CFT073
∆lysP
CFT073
∆argP
JJ1886
JJ1886
∆mppA
JJ1886
∆oppAB
CDF

CFT073; λred

amp
cat
kan
tet
amp (expression vector)
amp Para::lysP
amp Para::argP
kan, (∆N17)amiD-His6

pLysP
pArgP

J. Teramoto, K. A. Datsenko, and B. L. Wanner, unpublished
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CFT073; λred
46
JJ1886; λred
JJ1886; λred

43
43
B. Wannera
43
47
This study
This study
This study

Supplementary Figures
A

108 CFU CFT073

104 CFU CFT073

B

0h

24 h

Cell Length (µm)

C

48 h

30

20

10

0
0h

48 h

Fig. S1. Quiescent CFT073 cells are filamentous at 48 h. (A) CFT073 cells were
seeded on 0.2% glucose M9 minimal agar plates and incubated for 24 h at 37 °C at
low density (104 CFU), which promotes quiescence, and at high density (108 CFU),
which prevents quiescence and promotes proliferation, leading to a lawn of colony
growth on the agar plate. (B) CFT073 cells were grown on 0.2% glucose M9 minimal
agar plates at 37 °C, harvested at 0 and 48 h and visualized by DIC microscopy. Scale
bars are 5 μm in length. Arrows indicate position of failed septa. (C) Violin plot
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representing cell length distribution at 0 h (n = 200) and 48 h (n = 72), grown under
conditions described in (B).
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Fig. S2. UPEC strain growth in glucose M9 minimal medium. (A) CFT073,
CFT073 ∆lysP, CFT073 ∆argP and (B) JJ1886 were grown in 0.2% glucose M9
medium at 37 °C for 24 h with OD600 measured every 2 h from 0 to 12 h and 22 to 24
h. All strains grow robustly overnight in glucose M9 minimal medium.
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L-Lys + L-Met

D-Lys + L-Met

Dap + L-Met

L-Lys

D-Lys

Dap

104 CFT073

A

103 JJ1886

B

Fig. S3. D-lysine and diaminopimelic acid (Dap) fail to stimulate proliferation of
CFT073 and JJ1886 cells on glucose M9 minimal agar. (A) CFT073 (104 CFU) and
(B) JJ1886 (103 CFU) were seeded on 0.2% glucose M9 minimal agar and challenged
with a solution of either (A) L-lysine (1 mM) and L-methionine (1 mM), D-lysine (1
mM) and L-methionine (1 mM), Dap (1 mM) and L-methionine (1 mM), (B) L-lysine
(1mM), D-lysine (1 mM) or Dap (1 mM). Plates were incubated for 24 h at 37 °C and
imaged. Arrows indicate position of stimulant addition. Scale bars are 1 cm in length.
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Digested
DigestedPG
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S. aureus PG

D

B. subtilis PG

S. aureus PG

B. subtilis PG

103 JJ1886

104 CFT073

C

Fig. S4. E. coli, B. subtilis and S. aureus peptidoglycan fragments stimulate
proliferation of CFT073 and JJ1886 cells. (A, C) CFT073 (104 CFU) and (D)
JJ1886 (103 CFU) cells were plated onto 0.2% glucose M9 minimal agar plates and
challenged with a mixture of digested (A) CFT073 PG, (C, D) B. subtilis or S. aureus
PG or (A) PBS. Plates were incubated (D) 24 h at 37 °C and (A, C) 48 h at 37 °C. (B)
Digested E. coli PG was titrated (0 to 10 μg) on JJ1886 seeded plates and CFU per
zone was calculated. White arrows indicate position of stimulant addition. Scale bars
are 1 cm in length.

72

104 CFU
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B
CFT073 ∆lysP::kan

4-10.0 min

10.0-20.0 min

H2O

Pentapeptide
(A-E-K-A-A)

PG

CFT073

Fig. S5. Peptidoglycan fragments, including a S. aureus pentapeptide, stimulate
proliferation of quiescent UPEC cells. (A) CFT073 (104 CFU), CFT073 ∆lysP and
(B) JJ1886 (103 CFU) cells were plated onto 0.2% glucose M9 minimal agar and
challenged with a mixture of digested B. subtilis peptidoglycan (50 μg), S. aureus
pentapeptide (A-E-K-A-A) (5 μg) or water. Plates were incubated for 48 to 72 h at 37
°C in (A). (B) Quiescent JJ1886 cells were challenged with early (4 to 10 min) or late
(10 to 20 min) fractions of mutanolysin digested E. coli peptidoglycan fractionated by
HPLC. Plates were incubated for 24 h at 37 °C. Arrows indicate position of proliferant
addition and scale bars are 1 cm in length.
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Fig. S6. Candidate proliferants tested for reversal of JJ1886 quiescence. LCMS
profiles of total ion counts (TIC) for a tripeptide (acetyl-L-Lys-D-Ala-D-Ala), 331.25
[M+H]+ (m/z) (A), similar to an S. aureus PG fragment, which was tested for
stimulating proliferation of quiescent JJ1886 cells plated at 103 CFU per plate on 0.2%
glucose M9 minimal agar, inset; (B) elution of a PG pentapeptide identical to a S.
aureus fragment and corresponding test for quiescence reversal, inset; (C) Candidate
proliferants including NAG (0.4 mM), NAM (0.4 mM) and NAG-NAG (1 mM) were
tested for their ability to stimulate quiescent JJ1886 cells (103 CFU per plate) on 0.2%
glucose M9 minimal agar plates and plates were incubated for 24 h at 37 °C. White
arrows indicate position of proliferant addition and scale bars are 1 cm in length.
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Fig S7. E. coli peptidoglycan fragment analysis by tandem mass spectrometry.
Tandem mass spectrometry profiles showing total ion counts (TIC) for (A) crude
peptidoglycan extracted from E. coli and extracted ion counts (XIC) for fragments
from digested E. coli peptidoglycan and including LCMS/MS fragmentation for (B, E)
disaccharide tetrapeptide, (C, F) disaccharide tripeptide and (D, G) disaccharide
dipeptide.
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Fig. S8. Analysis of quiescence stimulation by PG tetra- and pentapeptides. E. coli
peptidoglycan tetrapeptide was generated in situ by digestion of disaccharide
tetrapeptide with purified AmiD. (A) AmiD as purified by IMAC and analyzed by
SDS-PAGE. (B) AmiD, disaccharide tetrapeptide and AmiD-digested disaccharide
tetrapeptide, which released NAG-NAM and tetrapeptide, were tested for the ability to
stimulate proliferation of quiescent JJ1886, JJ1886 ∆oppABCDF and JJ1886 ∆mppA
cells plated at 103 CFU on M9 minimal agar with 0.2% glucose or (C) quiescent
CFT073 cells plated at 104 CFU onto M9 minimal agar with 0.2% glucose and
incubated for 48 h. (D) S. aureus PG stem pentapeptide (L-Ala-D-Glu-L-Lys-D-AlaD-Ala) (5 μg) was tested for the ability to stimulate proliferation of quiescent JJ1886,
JJ1886 ∆oppABCDF and JJ1886 ∆mppA cells plated at 103 CFU on M9 minimal agar
with 0.2% glucose and incubated for 24 h at 37 °C. Where indicated, brackets
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highlight areas of stimulated growth and white arrows show position of stimulant
addition. Scale bar is 1 cm in length.
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CHAPTER 3

MANUSCRIPT 2: This manuscript has been written for publication in mSystems. The
formatting follows the guidelines set forth by the journal.
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Abstract
Bacteria produce a wide range of secondary metabolites that influence the health and
behaviors of neighboring cells. These chemically mediated interactions are difficult to
decipher since bacteria are both secreting and reacting to suites of compounds at any
given time. Visualization of these metabolic exchanges on agar surfaces has been
aided by Matrix-Assisted Laser Desorption Ionization-Time of Flight Imaging Mass
Spectrometry (MALDI-TOF IMS). In this study, we investigated chemical
interactions between colonies of two marine bacteria, Vibrio parahaemolyticus
PSU5429 and Bacillus pumilus YP001. When colonies of the two bacteria were
grown in close proximity on an agar surface, we observed commencement of
swarming motility by the V. parahaemolyticus. As the vibrios moved closer to the
Bacillus, a zone of bacteria lysis appeared around the B. pumilus colony. MALDITOF IMS suggested that lipopeptides secreted by the Bacillus were responsible for
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inducing swarming motility. Genomic and chemical investigation of YP001 verified
the production of lipopeptides and amicoumacin antibiotics, and purified compounds
recapitulated the induction of swarming and antibiosis, respectively, when tested
against V. parahaemolyticus. In this scenario, lipopeptide production induces the
vibrios to swarm towards a lysis zone, resulting in a possible ‘catch and kill’ effect.
These results demonstrate the complexity of behaviors and outcomes by microbes
under the simultaneous influence of different allelochemicals and suggest possible
interplays between antibiotics and compounds that induce motility.

Importance
Bacterial secondary metabolism provides a wealth of chemically diverse molecules
possessing wide-ranging biological activities. Many of these molecules are expected
to mediate interactions with other organisms, especially other microbes. However,
deciphering the possible ecological roles of individual compounds is difficult due to
small spatial scales and low compound abundance. In this study, we used a
combination of MALDI-TOF imaging mass spectrometry, biosynthetic gene cluster
analysis, and secondary metabolite identification to investigate chemical interactions
between the marine bacteria Vibrio parahaemolyticus and Bacillus pumilus. Our
results imply an interplay between lipopeptides produced by B. pumilus that induce
swarming motility in the vibrio, causing the latter to move toward an antibiotic lysis
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zone. These observations highlight the complexity of chemical interactions between
microorganisms when multiple compounds are simultaneously secreted and suggest
that multiple secondary metabolites could work in concert to influence outcomes.

Introduction
Microbial communities use chemical communication for synchronizing the
behaviors of cells, coordinating key processes such as movement, secretion of
secondary metabolites, bioluminescence, virulence factor production, and the
formation of biofilms (1). Bacteria also secrete molecules for defensive purposes, iron
acquisition, and to enhance motility, such as surfactants that modify surfaces to enable
coordinated movements such as swarming (2). These biosynthetic processes are
energetically expensive and ineffective strategies for individual cells but become
advantageous when undertaken collectively in a population.
Deciphering the intended ecological functions of microbial secondary
metabolites is challenging due to the small scales on which these interactions occur
and the complexity of unraveling simultaneous responses to multiple signals. Recent
advances in imaging mass spectrometry (IMS) techniques have helped enable the
visualization of chemically mediated microbial interactions (3). IMS methods, such as
Matrix-Assisted Laser Desorption Ionization-Time of Flight Imaging Mass
Spectrometry (MALDI-TOF IMS), provide a spatial map of ionizable molecules on a
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surface as they diffuse away from a source such as a microbial colony. Visualizing the
metabolic exchanges between groups of cells can provide clues to the ecological
functions of secondary metabolites and aid in the formulation of hypotheses for how
compounds influence competition outcomes.
Bacteria belonging to the genus Bacillus are recognized as prolific producers
of allelochemicals, especially biologically active peptides. The antibiotics polymyxin
B and colistin are examples of medically useful peptide drugs derived from Bacillus
species (4,5). Surfactins are cyclic lipopeptides that lower surface tension and enable
coordinated swarming, a form of social motility, observed with many Bacillus species
(6). Surfactins have also been implicated in antagonism toward other microbes,
initiation of biofilm production, surface attachment, and as chemoattractants (7-12).
MALDI-TOF IMS is particularly well suited to detection and characterization of
secreted peptides and has proven useful in prior studies of chemically-mediated
microbial interactions between Bacillus and other bacteria (12,13).
Our interest in bacteria interactions in marine aquaculture settings led us to
investigate the chemical interplay between Bacillus pumilus YP001 and V.
parahaemolyticus PSU5429, a prevalent marine pathogen in aquaculture. When cocultured on an agar surface, the vibrio colony was observed to commence swarming
motility in the direction of the Bacillus colony. As the vibrios approached the Bacillus
colony, a lysis zone became visible, suggesting that both chemoattraction and
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antibiosis were acting upon the motile vibrio cells. To better understand how
metabolic exchanges drive this microbial interaction, we combined MALDI-TOF
IMS, genome analysis, and studies of purified compounds. Here we demonstrate how
multiple compounds may act in concert to combine chemoattractant and antibiosis
effects on a community of V. parahaemolyticus.

Results
B. pumilus YP001 induces V. parahaemolyticus to swarm toward a lysis zone. B.
pumilus YP001 was isolated from an egg bearing female American lobster Homarus
americanus in Narragansett Bay, RI. As part of a binary screening effort to identify
marine bacteria displaying antibiosis toward Vibrio parahaemolyticus, we observed
that YP001 colonies created zones of inhibition when grown on a lawn of V.
parahaemolyticus PSU5429, suggesting the production of a compound(s) with growth
inhibitory properties (Figure 1b). To explore this interaction further, we next spotted
colonies of YP001 and PSU5429 in close proximity on YP30 agar plates.
Surprisingly, after incubation at 27 °C for 24 hours, the V. parahaemolyticus was
observed to commence swarming motility in the direction of the Bacillus colony
(Figure 2). However, at a distance of approximately 8 mm, the motile PSU5429
appeared to be impeded from closer approach to the YP001, further consistent with the
production of an antibiotic compound.
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MALDI-TOF IMS reveals metabolic exchanges between bacteria colonies and
suggests the role of lipopeptides in swarming by V. parahaemolyticus. We
hypothesized that bacterial secondary metabolites were responsible for the induction
of swarming motility by the vibrio and the lysis zone around the B. pumilus colony. A
MALDI-TOF IMS approach was implemented to visualize the presence of secondary
metabolites secreted by the two bacteria colonies as they interacted on a thin agar
plates. Bacillus are known to be versatile producers of bioactive peptides (14,15) and
MALDI-TOF is well suited for the detection of such molecules. This approach has
been previously applied to IMS investigations of secondary metabolism by Bacillus
growing on agar surfaces (12).
Colonies of YP001 and PSU5429 were cultured in close proximities (1, 8 and
13 mm) on thin agar (10 mL) YP30 plates in triplicate for 24, 48, and 96 h. Swarming
motility by PSU5429 and antibiosis were observed in these experiments after 24 hours
and continued up to 96 hours. Plates from each time point were prepared for MALDITOF IMS by fixing the thin agar onto a steel MALDI plate with matrix (50:50 αcyano-hydroxycinnamic acid and dihydroxybenzoic acid) and drying under
desiccation.
MALDI-TOF-IMS conducted in the positive ion mode revealed a 2-D spatial
map of chemical interactions between the two bacteria colonies (Figure 3). Prominent
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features included the secretion of compounds with m/z 1058 [M+Na]+ and 1072
[M+Na]+ surrounding the B. pumilus colony and extending to the area where V.
parahaemolyticus was swarming (Figure 3). The predicted size of these compounds
suggested that they could be lipopeptides. For example, the Bacillus secondary
metabolites surfactin C-15 and D (Figure S1 and S2) have molecular weights of
1035.68 and 1049.70, respectively, and therefore could account for the IMS observed
features. IMS showed that these molecules diffused all the way to the vibrio colony,
consistent with influencing of the observed swarming motility. Consistent with this
theory, surfactants are reported to modify surfaces to promote swarming motility of
bacteria such as observed for B. subtilis, Pseudomonas spp., Proteus mirabilis, V.
parahaemolyticus, and Serratia spp. (16-20). Additional signals with m/z 1050, 1058,
1059, 1072, 1073, 1086 and 1087 were also observed to diffuse away from the
Bacillus colony, and might indicate production of the related lipopeptides pumilacidin
A-C, and E-G respectively (Figure 3 and S3) (21). Compounds corresponding to these
ions were observed to diffuse across the agar surface in a manner similar to the
surfactins, further suggesting the production of pumilicidins as possible contributors to
the induction of swarming motility in the vibrios.
Other IMS features included ions localized within the zone of inhibition,
suggesting a possible role in the observed antibiosis (Figure 3). Prominent ions
included those with m/z 445, 467, 672, 823, and 899. Based on a review of antibiotic
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compounds produced by Bacillus species, the ions at m/z 445 and 467 were consistent
with the expected [M+H]+ and [M+Na]+, respectively, of the molecule amicoumacin
B, an antibacterial compound produced by a hybrid PKS-NRPS biosynthetic pathway
in Bacillus sp. (22).

Genome analysis of B. pumilus YP001 supports the production of lipopeptides
and amicoumacin antibiotics. IMS suggested roles of different compounds for
induction of swarming motility and antibiosis. Whole genome sequencing was
performed to investigate the biosynthetic potential of B. pumilus YP001 and possibly
identify secondary metabolites consistent with the IMS results. A draft genome from
YP001 was assembled and comprised 14 contigs, averaging 3,640,419 bp in size, with
an average GC content of 53.5%. The genome was annotated with the Rapid
Annotation Subsystem Technology (RAST) server, which identified 3,797 open
reading frames (23). The genome was next analyzed by antiSMASH (Antibiotics and
Secondary Metabolite Analysis Shell) (24) to identify biosynthetic gene clusters
(BSGs) involved in secondary metabolite production. Overall, 12% of the genome (i.e.
427,1038 nt) was broadly characterized as being involved in secondary metabolite
biosynthesis. The genome of B. pumilus YP001 encoded eleven major secondary
metabolism BGCs, including three non-ribosomal peptide synthase (NRPS) clusters,
two terpene biosynthesis pathways, type 1 polyketide synthase genes and one hybrid
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NRPS cluster. Alignments to previously published biosynthetic pathways were carried
out in Geneious (Figure S4).
Analysis of a NRPS cluster indicated that YP001 was capable of surfactin
production. This biosynthetic gene cluster showed 53.4% pairwise identity to the
surfactin producing proteins srfAA-D from Bacillus amyloliquefaciens BGC0000443
(Geneious Global alignment, 70% similarity cost matrix). Individual gene alignments
were carried out using NCBI-nBLAST, revealing strong similarities to the surfactin
synthase subunits srfAA (100%), srfAB (82%), srfAC (66%), and srfAD (64%) (Table
1).
The hybrid NRPS pathway was found to possess high pairwise identity
(64.1%) for the biosynthetic gene cluster (BGC) in Bacillus subtilis subsp.
inaquosorum KCTC 13429 that produces amicoumacin antibiotics (Geneious Global
alignment, 70% similarity cost matrix). Alignments of biosynthetic genes AmiA-M
from the KCTC 13429 strain showed high homology between these two biosynthetic
gene clusters (Table 2) (25). Amino acid binding site analysis was carried out using
Geneious to predict monomer substrate binding in adenylation and ketosynthase
domains (Table S1 and S2), further establishing a potential biosynthesis pathway for
amicoumacin production.
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Isolation and structure identification of lipopeptides, lipoamides and
amicoumacins produced by B. pumilus YP001. The results from the MALDI-TOFIMS experiments and genome analysis encouraged the isolation and structure
characterization of bioactive compounds produced by B. pumilus YP001 in order to
validate their identities and bioactivities. B. pumilus YP001was cultured in 9 x 1L of
artificial seawater supplemented with yeast (1 g/L) and peptone (5 g/L) in the presence
of XAD-16 resin (Figure S5). XAD resin adsorbs secondary metabolites secreted into
the media during bacteria growth and has been shown to increase the recovery of
secondary metabolites (26). After seven days, the resin was recovered by filtration,
extracted with organic solvents, and the resulting crude extract was partitioned
between ethyl acetate and water. The organic soluble compounds were fractionated by
C18 reversed-phase column chromatography and HPLC and guided by bioassays
against V. parahaemolyticus PSU5429. The bioassays indicated that separate
compounds were responsible for induction of swarming motility and antibiotic
activity. Specifically, the PSU5429 swarming motility was induced by fractions that
appeared enriched for lipopeptides by 1H NMR spectroscopy. In contrast, the
antibiotic activity, observed as zones of growth inhibition in disc diffusion assays,
tracked with fractions containing a compound with a m/z of 447 [M+Na]+.
Four compounds (1-4) were isolated from the culture extracts that promoted
swarming motility by PSU5429. Lipoamide B2 (1) was obtained as an optically active
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colorless oil {[α] 21.8 -7.0 (c 0.1, MeOH)}. High-resolution electrospray ionization
mass spectrometry (HRESIMS) analysis established the molecular formula of 1 as
C17H32N2O4 (m/z 351.2226 [M+Na]+, calcd. 351.2254), requiring three degrees of
unsaturation. The IR spectrum of 1 displayed characteristic absorptions indicative of
amide bond (νmax 1663 cm-1) (Figure 4). Its 13C NMR and DEPT spectra (Table S3),
combined with HSQC data, disclosed 17 carbon resonances, including two methyls,
ten sp3 methylenes, two sp3 methines, and three sp2 quaternary carbons (three carbonyl
carbons at δC 173.0, 172.3 and 171.9, two of which were assigned as amide carbonyl
carbons based on the MS and IR spectrum of 1. The above functional groups
accounted for all three degrees of unsaturation, implying a linear structure in 1.
The existence of an asparagine unit (unit A, Figure 5) was determined by the
clear 1H-COSY correlations of H-1’ (δH 7.94, d, J=7.5 Hz)/H-2’ (δH 4.45 m)/H2-3’ (δH
2.42, m; δH 2.56, m) and key HMBC correlations from these protons to C-6’ (δC
173.0) and C-4’ (δC 171.9), along with the identical HMBC correlations from H-1’ to
C-2’ (δC 48.9) and from H2-5’ (δH 6.85, s; δH 7.37, s) to C-4’. Two methyl signals at δH
0.83 (d, J= 6.6 Hz) and δH 0.80 (t, J= 7.5 Hz) and the broad signal at δH 1.23 strongly
indicated the presence of anteiso-methyl-branched fatty acid chain which was then
verified by the detailed analysis of COSY correlations of H3-12/H-10 (δH 1.32, m) and
H2-11 (δH 1.11, m; δH 1.32, m), H3-13/H2-9 (δH 1.07, m; δH 1.27, m) and H-10, as well
as the HMBC correlations from H3-12/H3-13 to C-10 and H-10 to C-9. Furthermore,
91

the HMBC correlation of H2-2 (δH 2.07, t, J= 7.2 Hz) and C-1 (δC 172.3), bearing in
mind the MS of 1, determined the presence of a 12-membered side chain with a C-1
acyl group and a methyl branch at the antepenultimate carbon (unit B, Figure 5).
Finally, the connection between two units (units A and B) was established by the
correlations from H-1’/H-2’/H2-2 to C-1, allowing the planar structure construction of
1. The NMR spectroscopic data of 2 indicated that its structure was closely related to 1
and represents a structural isomer of the previously published lipoamide C (27).
Parent masses are insufficient to differentiate lipopeptides produced by
Bacillus sp. therefore the identities of compounds 3 and 4 were determined by
extensive investigations of spectroscopic data. Pumilacidin and surfactin differ by one
amino acid residue at the fourth position, corresponding to leucine and valine,
respectively. Compound 3 was isolated from B. pumilus YP001 broth monoculture as
a white powder; [α] 21.8 -2.22 (c 0.2, MeOH). Prominent features in the 1H NMR
spectrum were consistent with lipopeptide structures, and 1H-1H COSY correlations,
identified spin systems corresponding to glutamic acid, leucine, and valine amino
acids (Figures S17, S19). The presence of leucine points strongly towards isolated
compounds 3 and 4 belonging to the family of surfactins known to be produced by
Bacillus pumilus. HRESIMS data confirmed the molecular formula of compound 3 to
be C53H93N7O13 (m/z 1034.6790 [M-H]-, calcd 1034.6753) corresponding with the
known surfactin C-15 (Figure S1).
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Compound 4 was isolated as a white powder; [α] 21.8 -4.07 (c 0.2, MeOH) from
broth monoculture and the molecular formula of compound 4 was established as
C54H95N7O13 based on HRESIMS (m/z 1048.7000 [M-H]-, calcd. 1048.6910) (Figure
S2). Based on this data in combination with one- and two dimensional NMR data,
compound 4 was identified as surfactin D. Comparison of the optical rotations of 3
and 4 against published values were consistent with these assignments of surfactin C15 and D (28). Taken in combination with BGC analysis, this evidence was confirmed
the structures of compounds 3 and 4.
Amicoumacin B was obtained as a yellow oil. Based on HRESIMS (m/z
447.1648 [M+Na]+) data we established a molecular formula as C20H32N2NaO4. The
1

H NMR spectra exhibited three aromatic proton singlets for a tri-substituted aromatic

unit at δH 6.81, 7.47, and 6.84 (H-5, H-6, and H-7), three oxymethines at δH 4.69, 3.95,
and 3.72 (H-3, H-8’ and H-9’), two nitrogen-bonded methines δH 4.20 and 3.31 (H-5’
and H-10’), and two methyl resonances at δH 0.85 and 0.89 (H-1’ and H-2’) consistent
with a isocoumarin ring structure (Table S4), and matching the published values for
amicoumacin B (insert ref containing published NMR data for amicoumacin B).
MALDI-TOF IMS was used to visualize the isolated amicoumacin B as it diffused
through agar from a 10 mM spot on a thin agar MALDI plate (Figure S6).
Amicoumacin B ionized readily by MALDI-TOF IMS, further confirming its identity
in the co-colony IMS experiments.
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V. parahaemolyticus swarms toward a source of highly purified surfactins or
lipoamides. A swarming motility assay was used to investigate the effects of specific
compounds on initiation of swarming by V. parahaemolyticus PSU5429. Close
proximity of PSU5429 to either B. pumilus YP001 or discs loaded with lipopeptide
compounds 1-4 stimulated swarming behavior (Figure 6). Isolated surfactins and
lipoamides stimulated swarming motility in PSU5439 with variable effects. Surfactins
C-15 and D induced strong directional swarming when loaded onto discs at 10 and
100 µg/disc (Figure 6). In comparison, lipoamides 1 and 2 caused weak swarming
response at 200 µg (Figure S6). No swarming was observed in response to discs
loaded with amicoumacin B (data not shown).
The motility bioassays were repeated against three other marine Vibrio sp. to
test if YP001 compounds could stimulate swarming motility in other species.
Swarming motility was induced by surfactin C-15 and D for in the oyster pathogen V.
coralliilyticus RE22, but not for V. harveyi BB120 or V. anguillarum NB10Sm.
Neither V. parahaemolyticus PSU5429 nor V. coralliilyticus RE22 were observed to
swarm in control experiments conducted in the absence of compounds from B.
pumilus YP001 (Figure S8). All four Vibrio sp. were susceptible to the antibiotic
effects of amicoumacin B (Figure 1b-d).
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Discussion
The IMS results showed that the Vibrio parahaemolyticus colony was
subjected to a barrage of secondary metabolites secreted by B. pumilus YP001, five of
which were identified using a combination of genome analysis and compound
isolation. Four molecules were found to promote swarming motility in V.
parahaemolyticus, namely surfactins C-15 and D and lipoamides B2 and C. In
addition, the isocoumarin antibiotic amicoumacin B demonstrated killing effects and
likely contributes to an observed zone of growth inhibition surrounding the Bacillus
colony.
MALDI-TOF IMS also revealed ions belonging to compounds that were not
isolated from broth cultures of YP001, and these might further contribute to the
microbial interactions. For example, ions observed by IMS suggest the production of
pumilacidins A, B, C, E, and G by B. pumilus YP001 (Figure 3 and S3). Other
molecules corresponding to ions concentrated in the antibiotic zone were not identified
as known Bacillus compounds or isolated from liquid monocultures of YP001. Taken
together, this shows that the vibrio cells experience a complex chemical environment
when in proximity to B. pumilus that influences both their phenotypes and survival.
One interpretation of these combined effects on the vibrio colony is that the
Bacillus colony promotes swarming motility toward a zone of growth inhibition,
resulting in lysis of nearby vibrio cells and providing additional nutrients to support
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colony growth. The closely related bacterium Bacillus subtilis has previously been
shown to engage in bacteria cannibalism, whereby a subpopulation secretes peptide
toxins to lyse sibling cells in order to harvest their nutrients (29). Bacillus subtilis
produces the proteins Slf and bacteriocin-like toxins which lyse nearby cells in a form
of bacterial cannabalism (30,31). The dual secretion of motility promoters and
antibiotics might serve a similar purpose in interspecies interactions. It was recently
shown that the bacterium Paenibacillus dendritiformis swarms toward a source of
surfactins, consistent with these molecules serving as interspecies recruitment factors
(12). The results here extend this possibility to more distantly related bacteria species,
since both V. parahaemolyticus and V. coralliilyticus commenced swarming motility
in response to the Bacillus lipopeptides. In contrast, the surfactins displayed no
growth alterations against V. harveyi and V. anguillarum NB10 (Figure S8), although
these bacteria do not possess the laf gene cluster most often conserved for the
production of lateral swarming flagellar (32,33).
An alternative hypothesis is that the V. parahaemolyticus benefits by coopting
surfactin production to enable its swarming motility. This could enable more rapid
colonization of the surrounding environment. Motility can increase antibiotic
resistance, up regulate virulence factor production and increase the speed of infection
on solid or semi solid surfaces such as tissues (34,35). While some bacteria species are
sensitive to the antimicrobial effects of lipopeptides, including clinically relevant
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Gram-positive and Gram-negative strain (36), others are clearly resistant and might
therefore capitalize on their surface modifying properties. In this instance, the
Bacillus might be producing antibiotics to fend off the approaching swarm of vibrios.
Motility in V. parahaemolyticus differs from other swarming bacteria because
it possesses two distinct flagellar systems. A single polar flagellum is utilized for
swimming while peritruchous lateral flagella are utilized during swarming (37). In
contrast to this study, lipopeptides were previously reported as inhibitors of swarming
motility in Vibrio alginolyticus (38). Surfactins act to decrease surface tension,
allowing directional movement of cells. Lipopeptides have also been shown to cause
ion channel formation in lipid bilayer membranes, creating imbalances in transmembrane ion fluxes (20,39,40). This proposed pore formation has been indicated as a
mechanism of action of surfactins as antimicrobial and antifungal agents (41-44). The
production of surfactin as a competitive interspecies chemical signaling strategy has
been shown for Salmonella, Escherichia, Bacillus and Staphylococcus species (45,46),
and now for Vibrio. Surfactins are also important mediators of intraspecies
communication and phenotypes, including promoting motility on surfaces, attachment,
and biofilm production (7-12). Hence, these molecules serve multiple purposes for
mediating both intra- and interspecies interactions.
Genome sequencing was employed to probe secondary metabolite biosynthetic
gene clusters and dereplicate IMS signals. Eleven biosynthetic gene clusters,
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accounting for 12% of the genome, were identified for YP001, suggesting the
impressive biosynthetic capabilities of this bacterium. This is comparable to Bacillus
subtilis which dedicates ~10% of its genome to secondary metabolism (36). Previous
bioinformatic investigation of Bacillus sp. found that strains contain 1 to 16 BGCs of
which some are highly conserved (NRPS, bacteriocin, and terpene) across all strains
whereas other BGCs (PKS, lanthipeptide and thiopeptide) are highly variable (47).
Combining genome mining with highly sensitive IMS techniques provided evidence
for the compounds involved in the observed microbial interactions, but chemical
isolations further verified several of the molecules. The bioassay guided approach also
helped identify lipoamides as inducers of swarming motility in V. parahaemolyticus.
Isocoumarin antibiotics such as the amicoumacins are commonly produced by
various species of Bacillus (48) as well as some actinomycetes (49). The
amicoumacins inhibit protein synthesis (50,51) and possess antibacterial properties
against clinically relevant Gram-positive bacteria (25). In this study we demonstrate
that the antibacterial activity of amicoumacin B against V. parahaemolyticus (Figure
7). Although purified amicoumacin B readily ionized on agar by MALDI-TOF IMS
and produced a ZOI against V. parahaemolyticus, production of amicoumacin B from
B. pumilus colonies was initially somewhat challenging to measure by IMS.
Differences could indicate that antimicrobial activities are predominantly cell-bound
or that the presence of the extracellular polysaccharide (EPS) matrix and other surface
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structures hinder the ionization of these molecules (13). Other high intensity ions were
present in the lysis zone surrounding the B. pumilus colony which were not identified,
suggesting that other anti-vibrio compounds might also contribute to the observed
antibiosis.
Bacillus and Vibrio species are ubiquitous in most marine environments and
are likely competitors for resources such as nutrients and space. The results from this
study suggest that these relationships are mediated by complex chemical interactions
where multiple secondary metabolites may work in concert to achieve advantageous
outcomes. Understanding the roles of specific molecules and their combinations could
help inform new ways to influence bacteria behaviors in aquaculture systems and treat
infections.

Materials and Methods
General experimental procedures: NMR experiments were conducted using an
Agilent Inova NMR 500 MHz spectrometer in DMSO-d6 (99.99%, Sigma-Aldrich, St.
Louis, MO, USA) at 25 °C (referenced to residual DMSO at δH 2.54 and δC 39.5).
High Resolution Electrospray Ionization mass spectra (HR-ESI-MS) and tandem mass
spectra were acquired using a TripleTOF 4600 spectrometer (AB Sciex) operating in
negative ion mode. Flash chromatography was completed using an Agilent 971-FP
flash purification system (Agilent Technologies, Santa Clara, CA, USA) with Biotage
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SNAP KP-C18-HS 120g cartridges (Biotage, Charlotte, NC, USA). HPLC
experiments were performed on a Shimadzu Prominence-I LC-2030C equipped with a
PDA detector model LC-2030/2040, pump LC-2030, and autosampler LC-2030.
Optical rotations were acquired on a Jasco P-2000 polarimeter and UV was taken on
Beckman Coulter DU 800. IR experiments were carried out on Thermo Nicolet 380
FT-IR. MALDI-TOF IMS was carried out on a Bruker Autoflex Speed instrument.

Isolation, sequencing and computational genome analysis of Bacillus pumilus
YP001. Strain YP001 was isolated from the egg mass of a female American lobster,
Homarus americanus, collected in Narragansett Bay (12/16/15; Fort Weatherall,
Jamestown, RI, USA). The eggs were gently brushed with a sterile cotton swab, which
was then stored in a sterile whirl-pak sampling bag for transportation to the lab. The
cotton tip was transferred into 1.5 mL of sterile artificial seawater (Instant Ocean ™;
Spectrum Brands) under aseptic conditions and then vortexed. A 100 µL aliquot was
plated on artificial seawater agar plates supplemented with yeast (1 g/L) and peptone
(5 g/L) (YP30). YP001 was picked from the plate as a single colony, streaked to purity
(twice on YP30 plates) and cryogenically stored at -80 °C in glycerol stocks.
Total DNA was extracted from overnight cultures of B. pumilus YP001 grown
in liquid YP30 using the Promega Wizard genomic DNA purification kit (Promega,
USA). The DNA was resuspended in 2 mM Tris-HCL buffer (Bio Basic). DNA was
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quantified using a NanoDrop 1000 spectrophotometer (ND-1000) and checked for
quality on a 1% agarose gel stained with ethidium bromide. The resulting DNA was
sequenced on an Illumina MiSeq sequencer at the Genomics and Sequencing Center at
the University of Rhode Island. Total genomic DNA was sheared by sonication
(Covaris S220), and paired end libraries were prepared using the SMARTer PrepX
DNA Library Kit on a SMARTer Apollo system (Takara Bio, USA). Reads were
trimmed using the CLC Genomic Workbench (version 9.5.3, Qiagen, Hilden,
Germany) for quality, ambiguous base pairs, adaptors, duplicates and size with default
parameters. A draft genome was assembled using the SPAdes assembler (Algorithmic
Biology Lab, St. Petersburg Academic University of the Russian Academy of
Sciences). Coverage was determined by mapping reads to a draft genome of Bacillus
pumilus (CP016784.1). The genome was annotated using the Rapid Annotation
Subsystem Technology (RAST) server and analyzed by antiSMASH (Antibiotics and
Secondary Metabolite Analysis Shell) for secondary metabolite biosynthesis gene
clusters. The draft genome assembly has been deposited in DDBJ/EMBL/GenBank
under accession number PRJNA434728. Sequence alignments for amicoumacin
biosynthetic cassettes were analyzed for identity through Geneious and NCBI-deltablastp.
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Isolation and Structure Elucidation of YP001 secondary metabolites. B. pumilus
YP001 was grown in 9 x 1 L of YP30 broth for 7 days at 25 °C and 150 rpm on a New
Brunswick C10 rotary shaker table in the presence of Amberlite XAD-16 resin (10
g/L; Sigma Aldrich). Following cultivation, the resin was collected by filtering
through two layers of cheesecloth, washed three times with DI water (4 L total) to
remove salts, and then extracted with 500 mL of 1:1 CH2Cl2 and CH3OH, followed by
1 L of CH3OH, and finally 200 mL EtOAc. The combined solvents were removed by
rotary evaporation and the resulting extract was partitioned between 100 mL H2O and
three washes of 500 mL ethyl acetate. The combined organic layers were concentrated
in vacuo to yield 0.8 g of extract.
The organic fraction was separated by flash chromatography using a
Combiflash Rf200 equipped with a 50 g C18 RediSepRf High Performance Gold
column (Teledyne ISCO). A linear solvent gradient of 5-100% CH3OH in H2O (0.1%
formic acid) was run over 20 min at a flow rate of 40 mL/min, then the mobile phase
was held at 100% CH3OH for 5 min. Individual peaks were collected by monitoring
UV absorbance at 254 nm, yielding 6 fractions (QW1-144-1 to QW1-144-6). HPLC
separations were completed with a Waters XBridge preparative C18 5 μm, 10 × 250
mm column at 4 mL/min a linear solvent gradient of 5-100% B (MeOH) run over 16
minutes against solvent A (water + 0.1% formic acid). Solvent B was held at 5% for 4
min prior to starting the gradient and 100% B was held for a subsequent 4 min
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following the gradient. Pure lipoamide B2, and C and were isolated by preparative
HPLC following the same solvent gradient yielding 11.8 mg and 11.9 mg respectively.
Analytical HPLC experiments were carried out on a Waters XBridge Analytical C18 5
μm, 4.6 × 250 mm column at 1 mL/min using the same mobile phase methods.
Purification of surfactin C15 and D followed a solvent gradient of 80-100% B
(MeOH) run over 16 min against solvent A (water + 0.1% formic acid). Solvent B was
held at 80% for 4 min prior to gradient beginning and 100% B was held for a
subsequent 4 min. Amicoumacin B was isolated to purity through flash
chromatography collection. In total, amicoumacin B, Surfactin C15, and surfactin D in
yields of 11.6 mg, 2.6 mg, and 6.3 mg, respectively.

Antimicrobial Activity Assays. B. pumilus YP001 was tested for antimicrobial
activity against the pathogens Vibrio anguillarum NB10Sm, Vibrio harveyi BB120,
Vibrio coralliilyticus RE22 and Vibrio parahaemolyticus PSU5429 through a
modified diffusion assay (52). V. parahaemolyticus PSU5429 was grown for 24 h in
YP30, diluted 10-3 fold, and 100 μL of the diluted culture was spread on 15 mL YP30
agar. A 5 μL spot of B. pumilus YP001, grown overnight in 10 mL YP30, was added
in triplicate and incubated at 25 °C. Zones of inhibition were imaged with a BioRad
gel doc universal hood after 24-48 h at 25 °C.
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Swarming Motility Assay. YP001 colonies, extracts and purified compounds were
tested for induction of swarming motility by V. parahaemolyticus PSU5429. Sterile
discs were loaded with 20 or 100 μg of test compounds and placed onto the surface of
a YP30 agar plate. Alternatively, a 5 μL spot of YP001 grown for 24 h in 5 mL of
YP001 broth was spotted onto a 15 mL YP30 agar plate. PSU5429 was grown for 24
h in YP30 broth, diluted to 1x105 CFU/mL in sterile media, and spotted at a distance
of 3, 8 or 13mm from the disc or colony. Plates were incubated for 24 h at 27 °C and
then imaged with a BioRad gel doc universal hood. This assay is qualitative for the
induction of swarming motility.

MALDI-TOF IMS Imaging. MADLI-TOF IMS experiments were carried out on 10
mL YP30 plates. Strains were plated in triplicate and incubated for up to 96 h. One
assay from each time point (24, 48 and 96 h) was wet mounted onto a steel MALDITOF plate, coated with 50:50 α-cyano-hydroxycinnamic acid (CHCA) and
dihydroxybenzoic acid (DHB) matrix and dried in a desiccator for 4 h at 37 °C and
analyzed by MALDI-TOF IMS. Samples were analyzed by MALDI-TOF IMS at 65%
laser power, 8.6X gain 500 μm raster in positive ion reflectron mode on a Bruker
Autoflex Speed instrument. Data was normalized using total ion count (TIC) or root
mean square (RMS) as indicated.

104

Acknowledgments
Research reported in this publication was made possible by the use of equipment and
services of the RI-INBRE Centralized Research Core Facility, which is supported by,
Rhode Island Institutional Development Award (IDeA) Network of Biomedical
Research Excellence from the National Institute of General Medical Sciences of the
National Institutes of Health under grant number P20GM103430. Sequencing work
conducted using the Rhode Island Genomics and Sequencing Center, which is
supported in part by the National Science Foundation (MRI Grant No. DBI-0215393
and EPSCoR Grant No. 0554548 & EPS-1004057), the US Department of Agriculture
(Grant Nos. 2002-34438-12688, 2003-34438-13111, and 2008-34438-19246) and the
University of Rhode Island.

References
1. Papenfort K, Bassler BL. 2016. Quorum sensing signal-response systems in
Gram-negative bacteria. Nat Rev Microbiol 14:576-588.
2. Daniels R, Vanderleyden J, Michiels J. 2004. Quorum sensing and swarming
migration in bacteria. FEMS Microbiol. 28:261-289.
3. Yang ZQ, Jiao X, Li P, Pan Z-M, Huang J-L, Gu R-X, Fang W-M, Chao G-X.
2009. Predictive model of Vibrio parahaemolyticus growth and survival on
salmon meat as a function of temperature. Food Microbiol 26:606-614.
105

4. Paulus H, Gray E. 1964. The biosynthesis of polymyxin B by growing cultures
of Bacillus polymyxa. J Biol Chem 239:865-871.
5. Koyama Y. 1950. A new antibiotic 'colistin' produced by spore-forming soil
bacteria. J Antibiot. 3:457-458.
6. Kearns DB, Losick R. 2003. Swarming motility in undomesticated Bacillus
subtilis. Mol Microbiol 49:581-590.
7. Raaijmakers JM, De Bruijn I, Nybroe O, Ongena M. 2010. Natural functions
of lipopeptides from Bacillus and Pseudomonas: more than surfactants and
antibiotics. FEMS Microbiol Rev 34:1037-1062.
8. Ron EZ, Rosenberg E. 2001. Natural roles of biosurfactants. Environ
Microbiol 3:229-236.
9. Chen Y, Cao S, Chai Y, Clardy J, Kolter R, Guo J-h, Losick R. 2012. A
Bacillus subtilis sensor kinase involved in triggering biofilm formation on the
roots of tomato plants. Mol Microbiol 85:418-430.
10. Gonzalez DJ, Haste NM, Hollands A, Fleming TC, Hamby M, Pogliano K,
Nizet V, Dorrestein PC. 2011. Microbial competition between Bacillus subtilis
and Staphylococcus aureus monitored by imaging mass spectrometry.
Microbiology 157:2485-2492.
11. Rosenberg G, Steinberg N, Oppenheimer-Shaanan Y, Olender T, Doron S,
Ben-Ari J, Sirota-Madi A, Bloom-Ackermann Z, Kolodkin-Gal I. 2016. Not so
106

simple, not so subtle: the interspecies competition between Bacillus simplex
and Bacillus subtilis and its impact on the evolution of biofilms. NPJ Biofilms
Microbiomes 2:15027.
12. Luzzatto-Knaan T, Melnik AV, Dorrestein PC. 2019. Mass spectrometry
uncovers the role of surfactin as an interspecies recruitment factor. ACS Chem
Biol 14:459-467.
13. Pabel CT, Vater J, Wilde C, Franke P, Hofemeister J, Adler B, Bringmann G,
Hacker J, Hentschel U. 2003. Antimicrobial activities and matrix-assisted laser
desorption/ionization mass spectrometry of Bacillus isolates from the marine
sponge Aplysina aerophoba. Mar Biotechnol 5:424-434.
14. Mondol MAM, Shin HJ, Islam MT. 2013. Diversity of secondary metabolites
from marine Bacillus species: chemistry and biological activity. Mar Drugs
11:2846-2872.
15. Stein T. 2005. Bacillus subtilis antibiotics: structures, syntheses and specific
functions. Mol Microbiol 56:845-857.
16. Gygi D, Rahman MM, Lai HC, Carlson R, Guard-Petter J, Hughes C. 1995. A
cell-surface polysaccharide that facilitates rapid population migration by
differentiated swarm cells of Proteus mirabilis. Mol Microbiol 17:1167-1175.
17. Andersen JB, Koch B, Nielsen TH, Sørensen D, Hansen M, Nybroe O,
Christophersen C, Sørensen J, Molin S, Givskov M. 2003. Surface motility in
107

Pseudomonas sp. DSS73 is required for efficient biological containment of the
root-pathogenic microfungi Rhizoctonia solani and Pythium ultimum.
Microbiology 149:37-46.
18. Lindum PW, Anthoni U, Christophersen C, Eberl L, Molin S, Givskov M.
1998. N-Acyl-l-homoserine lactone autoinducers control production of an
extracellular lipopeptide biosurfactant required for swarming motility of
Serratia liquefaciens MG1. J Bacteriol Res 180:6384-6388.
19. Julkowska D, Obuchowski M, Holland IB, Séror SJ. 2005. Comparative
analysis of the development of swarming communities of Bacillus subtilis and
a natural wild type: critical effects of surfactin and the composition of the
medium. J Bacteriol Res 187:65-76.
20. Ke WJ, Hsueh YH, Cheng YC, Wu CC, Liu ST. 2015. Water surface tension
modulates the swarming mechanics of Bacillus subtilis. Front Microbiol
6:1017-1017.
21. Naruse N, Tenmyo O, Kobaru S, Kamei H, Miyaki T, Konishi M, Oki T. 1990.
Pumilacidin, a complex of new antiviral antibiotics. Production, isolation,
chemical properties, structure and biological activity. J Antibiot 43:267-280.
22. Li Y, Li Z, Yamanaka K, Xu Y, Zhang W, Vlamakis H, Kolter R, Moore BS,
Qian PY. 2015. Directed natural product biosynthesis gene cluster capture and
expression in the model bacterium Bacillus subtilis. Sci Rep 5:9383.
108

23. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K,
Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL,
Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD,
Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The
RAST Server: rapid annotations using subsystems technology. BMC
Genomics 8:doi: 10.1186/1471-2164-9-75.
24. Weber T, Blin K, Duddela S, Krug D, Kim HU, Bruccoleri R, Lee SY,
Fischbach MA, Müller R, Wohlleben W, Breitling R, Takano E, Medema MH.
2015. antiSMASH 3.0-a comprehensive resource for the genome mining of
biosynthetic gene clusters. doi:10.1093/nar/gkv437.
25. Park HB, Perez CE, Perry EK, Crawford JM. 2016. Activating and attenuating
the amicoumacin antibiotics. Molecules 21(7): 824
doi:10.3390/molecules21070824.
26. Frykman S, Tsuruta H, Galazzo J, Licari P. 2006. Characterization of product
capture resin during microbial cultivations. J Ind Microbiol Biotechnol 33:445453.
27. Berrue F, Ibrahim A, Boland P, Kerr Russell G. 2009. Newly isolated marine
Bacillus pumilus (SP21): A source of novel lipoamides and other antimicrobial
agents. Pure Appl Chem 81(6):1027-1031.

109

28. Tang J-S, Gao H, Hong K, Yu Y, Jiang M-M, Lin H-P, Ye W-C, Yao X-S.
2007. Complete assignments of 1H and 13C NMR spectral data of nine surfactin
isomers. Magn Reson Chem 45:792-796.
29. Liu WT, Yang YL, Xu Y, Lamsa A, Haste NM, Yang JY, Ng J, Gonzalez D,
Ellermeier CD, Straight PD, Pevzner PA, Pogliano J, Nizet V, Pogliano K,
Dorrestein PC. 2010. Imaging mass spectrometry of intraspecies metabolic
exchange revealed the cannibalistic factors of Bacillus subtilis. PNAS
107:16286-16290.
30. Be’er A, Ariel G, Kalisman O, Helman Y, Sirota-Madi A, Zhang HP, Florin
EL, Payne SM, Ben-Jacob E, Swinney HL. 2010. Lethal protein produced in
response to competition between sibling bacterial colonies. PNAS 107:6258.
31. Claverys JP, Håvarstein LS. 2007. Cannibalism and fratricide: mechanisms
and raisons d'être. Nat Rev Microbiol 5:219-229.
32. Ormonde P, Hörstedt P, Toole R, Milton DL. 2000. Role of motility in
adherence to and invasion of a fish cell line by Vibrio anguillarum. J. Bacteriol
182:2326-2328.
33. Zhu S, Kojima S, Homma M. 2013. Structure, gene regulation and
environmental response of flagella in Vibrio. Front Microbiol 4:410-410.
34. Kearns DB. 2010. A field guide to bacterial swarming motility. Nat Rev
Microbiol 8:634-644.
110

35. Henrichsen J. 1972. Bacterial surface translocation: a survey and a
classification. Bacteriological reviews 36:478-503.
36. Das P, Mukherjee S, Sen R. 2008. Antimicrobial potential of a lipopeptide
biosurfactant derived from a marine Bacillus circulans. J Appl Microbiol
104:1675-84.
37. Verstraeten N, Braeken K, Debkumari B, Fauvart M, Fransaer J, Vermant J,
Michiels J. 2008. Living on a surface: swarming and biofilm formation. Trends
Microbiol 16:496-506.
38. Xiu P, Liu R, Zhang D, Sun C. 2017. Pumilacidin-like lipopeptides derived
from marine bacterium Bacillus sp. strain 176 suppress the motility of Vibrio
alginolyticus. Appl Environ Microbiol 83:e00450-17.
39. Gode-Potratz CJ, Chodur DM, McCarter LL. 2010. Calcium and iron regulate
swarming and type III secretion in Vibrio parahaemolyticus. J Bacteriol Res
192:6025-6038.
40. Mnif I, Ghribi D. 2015. Review lipopeptides biosurfactants: Mean classes and
new insights for industrial, biomedical, and environmental applications.
Biopolymers 104:129-147.
41. Ongena M, Jacques P. 2008. Bacillus lipopeptides: versatile weapons for plant
disease biocontrol. Trends, Microbiol 16:115-125.

111

42. Bender CL, Alarcon-Chaidez F, Gross DC. 1999. Pseudomonas syringae
phytotoxins: mode of action, regulation, and biosynthesis by peptide and
polyketide synthetases. Microbiol Mol Biol, Rev 63:266-292.
43. Baltz RH. Daptomycin: mechanisms of action and resistance, and biosynthetic
engineering. Curr Opin Chem, Biol 13:144-151.
44. Carrillo C, Teruel JA, Aranda FJ, Ortiz A. 2003. Molecular mechanism of
membrane permeabilization by the peptide antibiotic surfactin. Biochim
Biophys Acta 1:91-97.
45. Cao XH, Liao ZY, Wang CL, Yang WY, Lu MF. 2009. Evaluation of a
lipopeptide biosurfactant from Bacillus natto TK-1 as a potential source of
anti-adhesive, antimicrobial and antitumor activities. Braz J Microbiol 40:373379.
46. Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero
MG, Bessières P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A,
Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano
V, Carter NM, Choi SK, Codani JJ, Connerton IF, Cummings NJ, Daniel RA,
Denizot F, Devine KM, Düsterhöft A, Ehrlich SD, Emmerson PT, Entian KD,
Errington J, Fabret C, Ferrari E, Foulger D, Fritz C, Fujita M, Fujita Y, Fuma
S, Galizzi A, Galleron N, Ghim SY, Glaser P, Goffeau A, Golightly EJ, Grandi

112

G, Guiseppi G, Guy BJ, Haga K, et al. 1997. The complete genome sequence
of the Gram-positive bacterium Bacillus subtilis. Nature 390:249-256.
47. Grubbs KJ, Bleich RM, Santa Maria KC, Allen SE, Farag S, AgBiome T,
Shank EA, Bowers AA. 2017. Large-scale bioinformatics analysis of Bacillus
genomes uncovers conserved roles of natural products in bacterial physiology.
mSystems 2:e00040-17.
48. Itoh J, Omoto S, Shomura T, Nishizawa N, Miyado S, Yuda Y, Shibata U,
Inouye S. 1981. Amicoumacin A, a new antibiotic with strong antiinflammatory and antiulcer activity. J Antibiot 34:611-613.
49. Sun W, Zhang YQ, Huang Y, Zhang YQ, Yang ZY, Liu ZH. 2009. Nocardia
jinanensis sp. nov., an amicoumacin B-producing actinomycete. Int J Syst Evol
Microbiol 59:417-420.
50. Polikanov YS, Osterman IA, Szal T, Tashlitsky VN, Serebryakova MV,
Kusochek P, Bulkley D, Malanicheva IA, Efimenko TA, Efremenkova OV,
Konevega AL, Shaw KJ, Bogdanov AA, Rodnina MV, Dontsova OA, Mankin
AS, Steitz TA, Sergiev PV. 2014. Amicoumacin A inhibits translation by
stabilizing mRNA interaction with the ribosome. Mol Cell 20;56:531-540.
51. Lama A, Pané-Farré J, Chon T, Wiersma AM, Sit CS, Vederas JC, Hecker M,
Nakano MM. 2012. Response of methicillin-resistant Staphylococcus aureus to
amicoumacin A. PLOS One 7:e34037.
113

52. CLSI, M100-S25. Performance standards for antimicrobial susceptibility
testing; 25th informational supplement. Clinical and Laboratory Standards
Institute: Wayne, PA, 2016.

114

Figures
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Figure 1: Growth inhibition of B. pumilus YP001 against (a) V. harveyi BB120 (b) V.
parahaemolyticus PSU5429, (c) V. anguillarium NB10Sm, and (d) V. coralliitlyticus
RE22 after 24 h incubation on YP30 at 27 ºC.
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Figure 2: Swarming motility assay for B. pumilus YP001 plated in co-culture with V.
parahaemolyticus PSU5429 at concentrations of (a) 1x105 CFU/mL, (b) 1x102
CFU/mL, (c) 1x101 CFU/mL, and (d) no dilution. Plate was imaged after 24 h
incubation at 27 ºC.
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Figure 3: MALDI-IMS imaging shows the spatial distribution of compounds produced
during the chemical interaction of B. pumilus YP001 and V. parahaemolyticus
PSU5429.
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Table 1: Genes encoding the surfactin biosynthetic gene cluster in B. pumilus YP001,
their proposed functions and homology to the biosynthetic genes of B.
amyloliquefaciens BGC0000443. Alignments were carried out in NCBI-nBLAST.

B. pumilus YP001
Identity
(%)
E value
Protein Size (bp) Predicted Function
srfAA

10,755 NRPS

100%

0.0

srfAB

10,762 NRPS

82.0%

1e-07

srfAC

3,837 NRPS

65.7%

7e-69

64.3%

9e-13

100%

0.14

srfAD
ycxD

732 Thioesterase
1,311 Aminotransferase
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Table 2: Genes encoding the amicoumacin biosynthetic gene cluster in B. pumilus
YP001, their proposed functions and homology to the biosynthetic genes of B. subtilis
subsp. inaquosorum KCTC 13429. Alignments were carried out in NCBI-nBLAST.

Protein

B. subtilis YP001
E value
Size (bp) Predicted Function Identity (%)

AmiA

4,497 NRPS

65.1%

6e-84

AmiB

1,506 Peptidase

66.3%

2e-21

AmiD

702 Thioesterase

70.6%

5e-54

AmiE

345 Dehydrogenase

74.4%

9e-62

AmiF

213 Acyl carrier protein

78.9%

2e-23

Ami-1

9,096 NRPS-PKS

65.6%

0.0

Ami-2

2,670 NRPS

64.1%

1e-49

AmiJ

4,527 PKS

69.8%

0.0

AmiK

7,554 NRPS-PKS

71.9%

0.0

AmiL-M

6,429 NRPS-PKS

66.7%

0.0
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6 mm
Figure 6: Swarming bioactivity of compound 3 at 10 µg (a), 100 µg (b) and compound
4 at 10 µg (c), and 100 µg (d) after 24 h incubation at 27 ºC on YP30 agar.
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Figure 7: Effects of purified surfactin (20 µg/disk) and amicoumacin (20 µg/disk) (a),
surfactin (20 µg/disk) only (b), amicoumacin (100 µg/disk) only (c) and B. pumilus
YP001 colony (5 µL at 1x105 CFU/mL from a broth culture) (d) on V.
parahaemolyticus PSU5429 after 24 h incubation at 27 ºC.
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Supplementary Figures

Figure S1: High resolution TOF-MS for 3 m/z 1034.6790 [M-H]- in negative ion
mode. The declustering potential was set to -185 and collision energy to -33.
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Figure S2: High resolution TOF-MS for 4 m/z 1048.7 [M-H]- in negative ion mode.
The declustering potential was set to -200 and collision energy to -50.
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Figure S3: MADLI-TOF IMS total ion counts (TIC) taken after 48 h incubation
indicating the production of pumilacidin B (m/z 1,059 [M+Na]+), F/G (m/z 1,073
[M+Na]+), and E (m/z 1087 [M+Na]+).
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Figure S4: Biosynthesis of amicoumacin by B. pumilus YP001 domain predictions
carried out in Geneious.
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Table S1: Amino acid sequence alignment for amicoumacin production from B.
pumilus YP001.
Protein Size
(aa)

Proposed function

Identity
(%)

Accession No.

DW21908.1

Proposed Protein
Alignment
Orf1

2163

1413 Aminotransferase, class
III [B. pumilus]

99

2144

4416 Non-ribosomal peptide
synthetase [B. pumilus]

100

WP_080984813.1

AmiA

2143

1542 β-lactamase containing
hypothetical protein [B.
pumilus]

100

WP_050945729.1

AmiB

2142

981 Peptidase containing
hypothetical protein [B.
pumilus]

100

WP_050945730.1

AmiC

2141

711 Thioesterase [B.
pumilus]

100

WP_050945731.1

AmiD

2140

858 3-hydroxybutyryl-CoA
dehydrogenase [B.
pumilus]

100

WP_003214220.1

AmiE

2139

1056 Hypothetical protein [B.
pumilus]

100

WP_050945732.1

AmiF

2138

270 Acyl carrier protein [B.
pumilus]

100

WP_050945733.1

AmiG

2137

1143 Acyl-CoA
dehydrogenase [B.
pumilus]

100

WP_050945734.1

AmiH

2136

9090 Hybrid NRPS/T1PKS
[B. pumilus]

100

WP_050945735.1

AmiI

2135

2670 Non-ribosomal peptide
synthetase [B. pumilus]

100

WP_050945736.1

AmiJ

2134

4506 Polyketide synthase B.
pumilus]

100

WP_050945737.1

AmiK
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2133

7233 Polyketide synthase B.
pumilus]

100

MY19195.1

AmiL

2132

6411 Polyketide synthase B.
pumilus]

100

WP_050945739.1

AmiM

2130

1407 Alkaline Phosphatase
[B. pumilus]

100

WP_080984808.1

AmiN
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Table S2: Amino acid sequence alignment for surfactin production from B. pumilus
YP001.
Protein Size
(aa)

Proposed function

Identity/
Similarity
(%)

Accession No.

3473

1239 Hypothetical Protein [B. pumilus]

100

WP_050943243.1

3472

1299 Arsenical efflux pump membrane protein
ArsB [B. pumilus]

100

WP_050943242.1

3471

678 Amino acid transporter permease [B.
pumilus]

100

WP_003214368.1

3470

873 Amino acid ABC transporter substrate
binding protein [B. pumilus]

100

WP_050943239.1

3469

333 DUF2680 domain-containing protein [B.
pumilus]

100

WP_050943461.1

3468

765 MBL fold metallo-hydrolase [B. pumilus]

100

WP_050943237.1

3467

417 DNA-entry nuclease [B. pumilus]

100

WP_003214307.1

3466

807 AAC(3) family N-acetyltransferase [B.
pumilus]

100

WP_050943235.1

3465

387 DNA-entry nuclease [B. pumilus]

100

WP_050943233.1

100

WP_050943231.1

3464

1698 Methy;-accepting chemotaxis protein [B.
pumilus]

3463

429 DNA-entry nuclease [B. pumilus]

100

WP_003214307.1

3462

2070 Hydantoin utilization protein A [B.
pumilus]

100

WP_050943229.1

3461

1986 Hydantoin utilization protein B [B.
pumilus]

100

WP_050943227.1

3460

1086 ABC transporter ATP-binding protein [B.
pumilus]

100

WP_050943226.1

3459

1092 Polyamine ABC transporter ATP-binding
protein [B. pumilus]

100

WP_050943225.1

130

3458

870 ABC transporter protein permease [B.
pumilus]

100

WP_003214329.1

3457

804 ABC transporter protein permease [B.
pumilus]

100

WP_003214190.1

3456

10719 Non-ribosomal peptide synthetase [B.
pumilus]

92

WP_003214217.1

3455

3834 Non-ribosomal peptide synthetase [B.
pumilus]

100

WP_050945478.1

3454

10136 Non-ribosomal peptide synthetase [B.
pumilus]

100

WP_050945479.1

3453

8196 Non-ribosomal peptide synthetase [B.
pumilus]

100

WP_050945480.1

3452

741 Thioesterase [B. pumilus]

100

WP_050945481.1

3451

912 EamA family transporter [B. pumilus]

100

WP_050945482.1

3450

1338 PLP-dependant aminotransferase family
protein [B. pumilus]

100

WP_050945483.1
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B. pumilus YP001 9L Culture
1:1 DCM:MeOH
1L MeOH
200 mL EtOAc
XAD16 Resin Extract
2.61 g
Solvent partition between water and EtOAc
EtOAc Extract
0.8 g
C18 Reverse Phase Flash Chromatography 50 g C18 RediSepRf High Performance Gold
column
Lipophilic
Non-Polar

Polar
Tubes 1-12
QW1-144-1
85.4 mg

Tubes 13-15
QW1-144-2
44.9 mg

Tubes 16-18
QW1-144-3
34.7 mg

Tubes 19-23
QW1-144-4
86.2 mg

Tubes 24-25
QW1-144-5
25.9 mg

Tubes 26-43
QW1-144-6
435.8 mg

C18 Reverse Phase Semiprep HPLC

QW1-147-4
11.6 mg
QW1-152-4
3.6 mg

QW1-152-5
7.4 mg

QW1-152-6
9.0 mg
QW1-159-3
QW1-159-4
QW1-159-5
QW1-159-6
QW1-159-8
QW1-159-9

QW1-148-M1

Amicoumacin B

QW1-148-2
18.2 mg
AI-77-F

QW1-148-M2 QW1-148-3
14.1 mg
160.4 mg
Lipoamide C

QW1-148-M4
13.4 mg
Liposmide
B2

C18 Reverse Phase Semiprep HPLC
QW1-146-1

QW1-146-2

QW1-146-3
HR1-129-1
1.5 mg

Figure S5: Chemical isolation scheme from B. pumilus YP001.
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HR1-129-3
2.6 mg

HR1-129-4
6.3 mg

Surfactin C

Surfactin D

Table S3: 1H and 13C NMR data (δ in ppm, J in Hz) for compound 1 in DMSO-d6.
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
1’
2’
3’
4'
5’
6’

Type
qC
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH
CH2
CH3
CH3
NH
CH
CH2
qC
NH2
qC

δC
172.3
35.1
25.2
28.5
28.9
28.9
28.9
26.5
36.0
33.8
29.4
11.7
19.1
−
48.9
37.0
171.9
−
173.0

δH (J in Hz)
−
2.07 t (7.2)
1.45 m
1.23 m
1.23 m
1.23 m
1.22 m
1.27 m
1.07 m, 1.27 m
1.32 m
1.11 m, 1.32 m
0.80 t (7.5)
0.83 d (6.6)
7.94 d (7.5)
4.45 m
2.42 m, 2.56 m
−
6.85 s, 7.37 s
−

Recorded at 300 MHz for 1H NMR in DMSO-d6, chemical shifts (ppm) referred to DMSO (δH 2.50). Recorded at 125 MHz for 13C NMR
in DMSO-d6, chemical shifts (ppm) referred to DMSO (δC 39.5). Assignments were deduced by analysis of 1D and 2D NMR spectra.
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a

b

8 mm
Figure S6: Swarming assay for (a) lipoamide C (100 µg), and (b) lipoamide B2 (100
µg) against V. parahaemolyticus PSU5429 after 24 h incubation at 27 ºC.
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m/z 425 [M+H]+
m/z 447 [M+Na]+

Figure S7: MADLI-TOF IMS ionization of amicoumacin B m/z 425 [M+H]+ and 447
[M+Na]+ plated at 10 mM in methanol onto a YP30 plate.
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i

ii
b

a

b

c

c
a

6 mm

Figure S8: Swarming assay for 100 µg of surfactin D (i) and C-15 (ii) against (a)
Vibrio coralliilyticus RE22, (b) Vibrio harveyi BB120, (c) Vibrio anguillarum
NB10Sm after 48 h incubation at 27 ºC.
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Figure S9: 1H-NMR spectrum (500 MHz, DMSO-d6) of compound 1 from B. pumilus
YP001.
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Figure S10: 13C-NMR spectrum (500 MHz, DMSO-d6) of compound 1 from B.
pumilus YP001.
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Figure S11: 1H−1H COSY NMR spectrum (500 MHz, DMSO-d6) of compound 1 from
B. pumilus YP001.
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Figure S12: HSQC NMR spectrum (500 MHz, DMSO-d6) of compound 1 from B.
pumilus YP001.
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Figure S13: HMBC NMR spectrum (500 MHz, DMSO-d6) of compound 1 from B.
pumilus YP001.
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Figure S14: IR spectrum of compound 1.
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Figure S15: HRESIMS of compound 1 measured in positive ion mode (m/z 351.2226
[M+H]+ and 373.2048 [M+Na]+).
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Figure S16: Lipoamide C (2) IR data.
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Figure S17: HRESIMS of lipoamide C (2) recorded in positive ion mode (m/z 345.1713
[M+H]+).
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Figure S18: 1H-NMR spectrum (500 MHz, DMSO-d6) of surfactin D (4) from B.
pumilus YP001.
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Figure S19: 13C-NMR spectrum (500 MHz, DMSO-d6) of surfactin D (4) from B.
pumilus YP001.
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Figure S20: gCOSY-NMR spectrum (500 MHz, DMSO-d6) of surfactin D (4) from B.
pumilus YP001.
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Figure S21: TOCSY-NMR spectrum (500 MHz, DMSO-d6) of surfactin D (4) from B.
pumilus YP001.
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Figure S22: HSQC-NMR spectrum (500 MHz, DMSO-d6) of surfactin D (4) from B.
pumilus YP001.
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Figure S23: 1H-NMR spectrum (500 MHz, DMSO-d6) of surfactin C15 (3) from B.
pumilus YP001.
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Table S4. NMR Data for Amicoumacin B (500 MHz) in DMSO-d6.
Position
1
2
3
4
5
6
7
8
9
10
1’
2’
3’
4’
5’
6’
7’
8’
9’
10’
11’
12’

Type
CO
O
CH
CH2
CH
CH
CH
C
C
C
CH3
CH3
CH
CH2
CH
NH
CO
CH
CH
CH
CH2
CO
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δC
169.47
81.45
29.47
118.94
136.71
115.67
161.32
108.79
141.15
21.99
23.79
24.44
39.49
48.54
173.08
72.04
72.24
50.58
33.85
174.18

δH
4.69
2.85, 3.05
6.81
7.47
6.84
0.85
0.89
1.65
1.33, 1.67
4.20
7.90
3.95
3.72
3.31
2.18, 2.33
-

Table S5. NMR Data for AI-77-F (500 MHz) in DMSO-d6.
Position
1
2
3
4
5
6
7
8
9
10
1’
2’
3’
4’
5’
6’
7’
8’
9’
10’
11’
12’

Type
CO
O
CH
CH2
CH
CH
CH
C
C
C
CH3
CH3
CH
CH2
CH
NH
CO
CH
CH
CH
CH
CO
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δH
4.69
2.97
6.84
7.49
6.87
0.85
0.91
1.65
1.23, 1.68
4.20
7.70
-

-

Figure S24: 1H-NMR spectrum (500 MHz, DMSO-d6) of AI-77-F from B. pumilus
YP001.
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Aquimarina sp. I32.4 (formerly Aquimarina sp. ‘homaria’) is a putative pathogen
involved in epizootic shell disease in the American lobster Homarus americanus. We
report here the draft genome sequence for Aquimarina sp. I32.4 and describe virulence
factors that may provide insight into its mechanism of pathogenicity.

Epizootic shell disease (ESD) is a prevalent and uncontrolled disease affecting
the carapace of the American lobster Homarus americanus. ESD is characterized by
formation of lesions on the carapace that exhibit bacterial counts 2-4 orders of
magnitude higher than the surrounding area (1). The cause of ESD is still debated
within the scientific literature, but recent studies have suggested the presence of
Aquimarina sp. ‘homaria’ results in the exacerbation of lesions (2,3,4). Aquimarina
sp. I32.4 is a Gram negative, chitin degrading bacterium (5). To better understand the
mechanism of pathogenicity we announce the draft genome sequence of Aquimarina
sp. I32.4 and describe some potential virulence factors.

Aquimarina sp. I32.4 was grown in artificial seawater (Instant Ocean)
supplemented with yeast extract (1 g/L) and peptone (5 g/L) at 25 oC on an elliptical
shaker (New Brunswick) for 48 hours. Genomic DNA was isolated using Promega
Wizard DNA purification kit (Promega, USA) and DNA was resuspended in 2 mM
Tris-HCL buffer (Bio Basic). DNA was quantified using a NanoDrop 1000
spectrophotometer (ND-1000) and checked for quality on a 1% agarose gel stained
with ethidium bromide. DNA was sequenced on an Illumina MiSeq sequencer at the
Genomics and Sequencing Center at the University of Rhode Island. Reads were
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trimmed using the CLC Genomic Workbench (version 8.5.1) for quality, ambiguous
base pairs, adaptors, duplicates and size resulting in 1,329,308 paired-end reads. The
draft genome was assembled using the de novo assembly algorithm of SPAdes
assembler (version 3.1.1). Contigs with coverage of >22 reads were processed using
the CLC Microbial Genome Finishing module with Aquimarina macrocephali JAMB
N27 (GCA_000520995.1) used as a reference genome. The completed draft genome is
composed of 244 contigs, averaging 20,446 bp in size (total genome = 4,988,869 bp),
with an average G+C content of 32.4%. The draft genome was annotated using the
Rapid Annotation Subsystem Technology (RAST) server and resulted in 4,469 open
reading frames (6). The closest neighbor identified by SEED viewer 2.0 (7) was
Gramella forsetii KT0803 (score = 541).

The annotated draft genome of Aquimarina sp. I32.4 encodes for type III and
IV secretion systems. It has previously been reported that Aquimarina sp. can degrade
the carapace of H. americanus (1). Accordingly, sixteen putative chitinase genes were
found, along with three hemolysins and three metalloproteases. Three iron acquisition
systems were annotated: TonB, including the full compliment of proteins responsible
for the formation of the TonB-ExbB-ExbD complex, hemin and ferric siderophores
were identified and could contribute to virulence associated with this strain. The
RAST annotated draft genome was submitted to antiSMASH (Antibiotics and
Secondary Metabolite Analysis Shell) for secondary metabolite biosynthesis gene
cluster analysis (8). Identification of ten clusters for secondary metabolism including,
T1PKS-NRPS biosynthesis, NRPS and Trans-ATPKS were categorized by
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antiSMASH. Trans-ATPKS biosynthesis produces structurally diverse molecules in
other bacteria, including the cytotoxic and antitumor compounds pederin and
onnamide (9). Other species in this genus have been shown to have algicidal activity
against toxic cyanobacterium strains (10).

This Whole Genome Shotgun project has been deposited at
DDBJ/ENA/GenBank under the accession number PGUB00000000. The version
described in this paper is version PGUB00000000.
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ABSTRACT
Thalassobius sp. 31.1 is a putative pathogen involved in epizootic shell disease in
the American lobster Homarus americanus. We report here the draft genome
sequence for Thalassobius sp. 31.1 and provide insight into its metabolism and
links to environmental pollutant degradation.

Thalassobius sp. 31.1 is a Gram-stain-negative, aerobic, motile, rod-shaped
bacterial strain. This genus is of the class Alphaproteobacteria, family
Rhodobacteraceae, and order Rhodobacterales. Thalassobius sp. 31.1 was isolated
from a lesion on the carapace of the American lobster Homarus americanus (1).
Lesions are the characteristic symptom of epizootic shell disease (ESD) and
Thalassobius has been indicated as a putative pathogen in lesion formation. Strains of
the genus Thalassobius have previously been studied for the inability to utilize
multiple carbon sources (2). However, Thalassobius has been shown to utilize the
speculative environmental carcinogen phthalate, a chemical widely used in the
manufacture of plastics, lubricants and textiles (3). These strains contain genes
required for poly-beta-hydroxybutyrate (PHB) synthesis and genes relating the
degradation of phenylacetates, an abundant class of environmental pollutants (4).

Thalassobius sp. I31.1 was grown in artificial seawater (instant ocean)
supplemented with yeast (1 g/L) and peptone (5 g/L) at 25 °C on an elliptical shaker
(New Brunswick) for 48 hours. Genomic DNA was isolated using Promega Wizard
DNA purification kit (Promega, USA) and DNA was resuspended in 2 mM Tris-HCL
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buffer (Bio Basic). DNA was quantified using a NanoDrop 1000 spectrophotometer
(ND-1000) and checked for quality on a 1% agarose gel stained with ethidium
bromide. The DNA was sequenced on an Illumina MiSeq sequencer at the Genomics
and Sequencing Center at University of Rhode Island. Reads were trimmed using the
CLC Genomic Workbench (version 8.5.1) for quality, ambiguous base pairs, adaptors,
duplicates and size resulting in 2,277,834 paired-end reads. The draft genome was
assembled using the de novo assembly algorithm of SPAdes assembler (version 3.1.1).
Contigs with coverage of >44 reads were processed using the CLC Microbial Genome
Finishing module. The completed draft genome is composed of 62 contigs, averaging
57,385 bp in size, with an average G+C content of 55.1%. The draft genome was
annotated using the Rapid Annotation Subsystem Technology (RAST) server and
resulted in 3,749 open reading frames (5). The closest neighbor identified by SEED
viewer 2.0 (6) was Silicibacter pomeroyi DSS-3 (score = 508).

The annotated draft genome of Thalassobius sp. 31.1 encodes for type I and
II/IV secretion systems. RAST annotation identified a suite of paa genes involved in
phenylacetate degradation, two alkane monooxygenase genes, phbF, a transcriptional
regulator involved in PHB synthesis (7) and one toluenesulfonate dehydrogenase. The
annotated draft genome was submitted to antiSMASH (Antibiotics and Secondary
Metabolite Analysis Shell) for secondary metabolite biosynthesis gene cluster analysis
(8). Identification of six clusters for secondary metabolism including, homoserine
lactone, bacteriocin and lantipeptide-bacteriocin were identified.
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This Whole-Genome Shotgun project has been deposited in
DDBJ/EMBL/GenBank under accession number PWAA00000000. The version
described in this paper is the first version, PWAA01000000.
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Loktanella maritima YPC211 was isolated from the American lobster Homarus
americanus. We report here the draft genome sequence for L. maritima YPC211 and
identify genes of potential importance to it’s role within the microbial community.

Loktanella maritima is a Gram negative aerobic bacterium that was originally
isolated from shallow marine sediments in the Sea of Japan (1). Loktanella spp. appear
to be ubiquitously distributed in the oceans and have been isolated from Antarctic to
sub-tropical environments (6). The genus belongs to the class Alphaproteobacteria,
family Rhodobacterales, and order Rhodobacteraceae. Trappen et al. (2) originally
proposed the genus to accommodate three species but it has since been expanded and
modified to contain 15 species (3, 4, 5). The strain Ha06YPC211 produces a
beige/yellow pigment and was isolated from an egg mass of an American Lobster
(Homarus americanus) from Jamestown, RI.

L. maritima YPC211 was grown in artificial seawater (Instant Ocean)
supplemented with yeast extract (1 g/L) and peptone (5 g/L) at 25 °C on an elliptical
shaker (New Brunswick) for 24 hours. Genomic DNA was isolated using Promega
Wizard DNA purification kit (Promega, USA) and DNA was resuspended in 2 mM
Tris-HCL buffer (Bio Basic). DNA was quantified using a NanoDrop 1000
spectrophotometer (ND-1000) and checked for quality on a 1% agarose gel stained
with ethidium bromide. The DNA was sequenced on an Illumina MiSeq sequencer at
the Genomics and Sequencing Center at University of Rhode Island. Reads were
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trimmed using CLC Genomic Workbench (version 8.5.1) for quality, ambiguous base
pairs, adaptors, duplicates and size resulting in 4,491,164 paired-end reads. The draft
genome was assembled using the de novo assembly algorithm of CLC Genomic
Workbench and SPAdes assembler (version 3.1.1). Contigs with coverage of >76
reads were processed using the CLC Microbial Genome Finishing module. The
completed draft genome is composed of 13 contigs averaging 264,067 bp in size and 3
plasmids of 23,839, 6,277 and 215,371 bp in size (total genome = 3,678,360 bp), with
an average G+C content of 53.5%. The draft genome was annotated using the Rapid
Annotation Subsystem Technology (RAST) server and resulted in 3,681 open reading
frames (7).

The annotated draft genome of L. maritima YPC211 encodes for type I, II, III,
and IV secretion systems. It has previously been reported that Loktanella spp. can
survive temperature extremes and have been isolated from Antarctic mats (2).
Accordingly, five putative cold-shock proteins (including: CspA, CspB and CspC)
were annotated. Additionally, the genome encodes for four hemolysins, two
metalloproteases and one extracellular protease. Two iron acquisition systems, TonB
and Hemin (HmuS), were annotated as well as iron-specific hemin and ABC
transporters. Ferric siderophore related genes were also identified. The RAST
annotated draft genome was submitted to antiSMASH (Antibiotics and Secondary
Metabolite Analysis Shell) for secondary metabolite biosynthesis gene cluster analysis
(8), leading to the identification of four clusters, including a non-ribosomal peptide
synthetase, type I polyketide synthase, bacteriocin and homoserine lactone
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biosynthetic gene clusters. L. maritima YPC211 inhibits the growth of the shrimp
pathogen Vibrio parahaemolyticus when co-cultivated on an agar surface, as
determined by a zone of inhibition assay (9). Further investigation of these
biosynthetic gene clusters may aid in characterization of compounds responsible for
this antibiosis.

This Whole Genome Shotgun project has been deposited in
DDBJ/ENA/GenBank under accession number PKFN00000000. The version
described in this paper is the first version, PKFN01000000.
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CONCLUDING REMARKS

Antibiotics have been our frontline defense against bacterial infections for
decades. However, the increased emergence of antibiotic resistant infections has led to
a world health crisis. Continued use of broad spectrum antibiotics has caused an
increase in untreatable and fatal bacterial infections. In this dissertation I have
explored the potential use of chemical signals to help mediate pathogenic bacterial
infections. Understanding these chemical signaling strategies may help facilitate new
treatment strategies.
Nature has had billions of years of natural selection to perfect chemical
communication. Bacteria are particularly interesting as their rate of genetic change is
so high. We are continually reminded that this has driven systems that have no
redundancy; nothing is made by accident or without purpose. This dissertation shows
that even very small molecules such as peptidoglycan fragments, previously thought to
be innocuous, modulate extremely important communications in bacteria.
Understanding these natural communication pathways could be extremely important in
treating complex diseases. Bacteria depend on chemical cues for cell-cell
communications to facilitate group decision making and thus are key to survival. All
bacteria are capable of manipulating their chemical environment to survive.
This dissertation works across human health and marine bacterial biodiversity
to harness the potential of genetically unique bacteria to produce novel chemical
scaffolds. Most of the world’s microorganisms have yet to be cultured; many of these
are likely to be in a quiescent state and could harbor therapeutically useful natural
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products. Genomic data is extremely powerful in predicating biosynthetic pathways
from unculturable bacteria, allowing targeting of novel natural products.
Swarming motility and quiescence are phenomenon observed in disease
causing bacteria. Targeting these strategies for disease persistence as an alternative or
in combination with antibiotic treatment could significantly decrease the rate of
antibiotic consumption.
We are currently in the “post antibiotic era” and the one size fits all approach
to medicine is being overtaken by personalized medical treatment. Approaching
bacterial infections through phenotype modulation and control of signaling pathways
could allow prevention of disease progression without the threat of developing drug
resistance. This body of work helps to increase our understanding of how specific
chemical signaling pathways work and provides knowledge of potential avenues for
alternative treatment of bacterial infections.
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Peptidoglycan sensing prevents quiescence and promotes quorum-independent growth
of uropathogenic Escherichia coli
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Additional Results

Additional figures include isolation schemes for peptidoglycan from live cell
culture and support structure assignments for muropeptides based on MS/MS
fragmentation. Further figures show peptidoglycan recycling within the cell and
indicate E. coli knockout mutants that were made to strengthen this manuscript.
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E. coli CFT073 grown in M9 broth

Peptidoglycan extracted

LC-MS analysis

Quiescence bioassay

Base peak
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2.0E5

1.0E5

0.0E0

Crude Peptidoglycan

Purification by HPLC

Base peak
Intensity (TIC)

3.0E5
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Figure 1: Peptidoglycan isolation scheme indicating bioassay guided fractionation of
crude peptidoglycan digestion product from E. coli CFT073.
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E. coli CFT073 plated on LB and incubated for 24 h at 37 ºC.

Single colony picked and innoculated into 10 mL of M9 broth and
incubated at 37 ºC shaking 150 rpm for 24 h.

5 mL of broth culture innoculated into 1 L of M9 borth media and
incubated at 37 ºC at 150 rmp for 24 h.

All cells collected into 4 x 50 mL falcon tubes by multiple rounds
of centrifugation at 5,000 g for 10 min.

Each pellet was resuspended in 3 mL of M9 media.
6 mL of 6 % SDS was added to each tube while
being boiled and stirred. This was allowed to
continue for 3 h.
Centrifuged repeatedly at 262,000 x g until all of
the SDS was removed by washing with LCMS water.
Pellet resuspended in 10 mM Tris-HCL with 0.06% w/v NaCL.
100 μg of Pronase E added and incubated for 2 h at 60 ºC.
200 μL of 6 % SDS was added and pellets were boiled at
100 ºC for 30 min.
Centrifuged at 262,00 x g for 30 m in to remove SDS with
LCMS water.
Pellet re-suspended in 200 μlL of PBS.
Digested with 200 U of mutanolysin at 37 ºC overnight.
Cenreifuged at 16,000 x g for 10 m in.
‘Crude’ peptidoglycan.

Figure 2: Isolation methods for peptidoglycan from E. coli CTF073 cells to produce
‘crude’ peptidoglycan preparations used for testing in the quiescence bioassay.
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Figure 3: Synthesis, recycling and catabolism pathways for peptidoglycan in the cell.
Indicating transporters on the cellular membrane involved in uptake and regulation
into the cell. All mutant knockout (MppA, Opp and AmpG) pathways target different
sources of peptidoglycan transport.
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Figure 4: High resolution tandem mass spectrometry for disaccharide tetrapeptide
(NAG-NAM-Ala-Glu-DAP-Ala) as a potential constituent of crude peptidoglycan
preparations. Total ion counts (TIC) for crude peptidoglycan (a), extracted ion counts
(XIC) for disaccharide tetrapeptide (b), and MS/MS fragmentation of disaccharide
tetrapeptide mass to confirm its structure (c).
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Figure 5: High resolution tandem mass spectrometry for disaccharide tripeptide
(NAG-NAM-Ala-Glu-DAP) as a potential constituent of crude peptidoglycan
preparations. Total ion counts (TIC) for crude peptidoglycan (a), extracted ion counts
(XIC) for disaccharide tripeptide (b), and MS/MS fragmentation of disaccharide
tripeptide mass to confirm its structure (c).
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Figure 6: High resolution tandem mass spectrometry for disaccharide dipeptide (NAGNAM-Ala-Glu) as a potential constituent of crude peptidoglycan preparations. Total
ion counts (TIC) for crude peptidoglycan (a), extracted ion counts (XIC) for
disaccharide dipeptide (b), and MS/MS fragmentation of disaccharide dipeptide mass
to confirm its structure (c).
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Figure 7: High resolution tandem mass spectrometry for pentapeptide (Ala-Glu-DAPAla-Ala) as a potential constituent of crude peptidoglycan preparations. Total ion
counts (TIC) for crude peptidoglycan (a), extracted ion counts (XIC) for pentapeptide
(b). Ion abundance was too low to accurately assess the structure by MS/MS.
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Figure 8: High resolution tandem mass spectrometry for tetrapeptide (Ala-Glu-DAPAla) as a potential constituent of crude peptidoglycan preparations. Total ion counts
(TIC) for crude peptidoglycan (a), extracted ion counts (XIC) for tetrapeptide (b), and
MS/MS fragmentation of tetrapeptide mass to confirm its structure (c).
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Figure 9: High resolution tandem mass spectrometry for tripeptide (Ala-Glu-DAP) as
a potential constituent of crude peptidoglycan preparations. Total ion counts (TIC) for
crude peptidoglycan (a), extracted ion counts (XIC) for tripeptide (b). Ion abundance
was too low to accurately assess the structure by MS/MS.
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Cam Pickard, 16S sequencing was done by Grace Underwood. All adult and PL
lobster trials were carried out by M.H., B.S., M.H., and K.C.

Additional Results

1.1 Bacterial isolation and culture conditions

Bacterial isolations were carried out from field collection swabs of live wild
lobsters in Narragansett Bay (12/10/15; Fort Wetherall, Jamestown, RI, USA). Swabs
were transported from the field site to the lab in sterile Whirl-Pak sampling bags and
transferred into 1.5 mL of sterile artificial seawater (Instant Ocean ; Spectrum
Brands) under aseptic conditions. These stocks were then vortexed and diluted 10- and
100-fold and stored at 4 ºC. Each sample was plated onto artificial seawater (Instant
Ocean) agar plates (ASW), ASW supplemented with yeast (1 g/L) and peptone (5 g/L)
(YP30) and, YP30 with chitin (30 g/L). Single, morphologically unique colonies were
picked, streaked to purity (twice on YP30) and cryogenically stored at -80 ºC in 10 %
glycerol. A total of 211 bacterial isolates were collected and cataloged for probiotic
screening.

1.2 Screening against putative pathogens

All 211 bacterial isolates were assessed for antimicrobial activity against the
putative pathogens involved in lobster shell disease (LSD) (Aquimarina sp. strain
I32.4 and Thalassobius sp. strain I31.1) and a common fish pathogen Vibrio
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anguillarum NB10Sm through a modified diffusion assay. A 24 h culture of the
pathogen was spread over the surface of the agar plates to form a lawn and 5 µL spots
from 24 h broth cultures of each isolate were added in triplicate and incubated at 25
ºC. Zones of inhibition (ZOIs) were measures after 24 and 48 h under optimal growth
conditions for the indicator strains (Table 1). Inhibitory zones were measures using
EVOS light microscope (Life Technologies). Tests were performed in triplicate with
measurements taken from the edge of the test colony to the first viable colony of the
indicator strain.

1.3 Characterization of pathogenic bacteria

Initial efforts concentrated on optimization of growth conditions for these
pathogenic bacteria. Thalassobius could be easily and rapidly grown in liquid media,
however Aquimarina could not. Table 2 summarizes some of the growth condition
attempted to remove the clumping nature of the strains as it interfered with an accurate
assessment of cellular growth by both OD600 and CFU/mL counts. Both are important
for developing bioassays for probiotic testing (work carried out by Jason LaPorte and
Edward Spinnard).
A computational approach and whole genome sequence analysis was undertaken
to gain a better understanding of the chemical diversity of these strains. Although the
genomes for the wild type strains were not available, closely related species of
Aquimarina showed the potential for extreme chemical diversity in their biosynthetic
gene clusters (GCGs) (Table 3). Comparably fewer genomes were available for
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Thalassobius sp. but many important BCGs were identified (Table 4). The methods
and results obtained from this analysis are published in manuscripts 2, 3, 4, and 5.

1.4 Characterization of probiotic bacteria

Initial screening resulted in the identification of 26 putative probiotic strains.
These strains were sequenced according to 16S rRNA PCR. Once potential phylogeny
was substantiated whole genome sequencing was carried out for phylogenetically and
chemically unique organisms Bacillus pumilus YP001, Loktanella maritima YPC210
and YPC211.

1.5 Chemical isolations from probiotic bacteria

Putative probiotic strains were grown in 1L YP30 broth cultures in the
presence of XAD16 resin for 1 week, after which the resin was filtered through a
double layer of cheese cloth and extracted with 50:50 dichloromethane (DCM) and
methanol (MeOH). These ‘crude’ extracts were subsequently tested in a modified disc
diffusion assay to assess their antibiotic effects against V. anguillarum (Table 5).
Neither Loktanella strain was able to produce a ZOI from monoculture extracts. This
topic is covered more thoroughly in appendix B.

1.6 NO to stimulate chemical diversity
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To stimulate the expression of potentially silent BSGs, literature reports have
suggested the use of oxidative stress to produce novel compounds. Preliminary testing
indicated that sodium nitroprussate concentrations of 1 µM and 10 µM were sublethal
where as 100 µM and 1,000 µM were both lethal for probiotic strain. Bacterial strains
(Thalassobius sp. I31.1, Bacillus pumilus YP001, Pseudoalteromonas sp. YPC21,
Loktanella maritima YPC210 and, Loktanella maritima YPC211) were streaked from
freezer stocks onto YP30 agar and incubated for 48 h, after which a single colony was
inoculated into 5 mL of YP30 broth and further incubated for 48 h at 25 ºC 150 rpm.
The cultures were assessed for CFU/mL using methods outlined previously. Cultures
were then spiked with sodium nitroprussate (SNP) at final concentrations of 1 µM and
10 µM. Cultures were allowed to incubate for a further hour before the addition of
sterile XAD16 resin and a further 24 h before chemical extraction. Resin was filtered
through a double layer of cheesecloth and extracted with 100 mL of 50:50
dichloromethane and methanol. Extracts were assessed for their novel metabolite
profiles via high performance liquid chromatography (HPLC) when compared to the
same strain under optimal growth conditions. Initial small-scale extraction cultures
showed no oxidative stress induced novel secondary metabolite production (Figure 1).
Chromatographic methods utilized a gradient solvent scheme, maintaining 95 % water
modified with 0.1 % formic acid and 5 % methanol for 4 minutes. Gradient than ran
for 20 minutes up to 100 % methanol, where it was held for an additional 4 minutes.
Experiments were carried out on a Shimadzu prominence-I LC-2030C equipped with a
PDA detector model LC-2030/2040, pump LC-2030, and autosampler LC-2030. The
column used was XBridge BEH 5 µm C18, 130 Å, column (4.6 mm X 250 mm).
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1.7 Preparation of combined Loktanella maritima (strains YPC210 and YPC211)
probiotics for in vivo trials of adult H. americanus

Probiotic bacteria were grown in YP30 media for 48 h shaking at 25 °C until a
dense culture was formed. 500 µL of culture stock was inoculated into 100 mL of
fresh YP30 media and incubated at 25 °C and 125 rpm for 24 h. Cell density was
measured by absorbance at 600 nm from 100 µL samples on a 96 well plate reader
(Molecular Devices, Spectromax M2). Cultures were also plated to count CFU/mL
and form a growth curve from which to measure the probiotic inoculum (Figure 2)
Each adult lobster was contained in individual 10 gallon aquarium tanks with
an ambient water flow through system and a day/night light cycle at the Graduate
School of Oceanography. Before treatment each lobster was scrubbed with fresh water
to control for native biofilms. Ten lobsters were kept as a control and an addition 10
were treated with a probiotic cocktail consisting of 2x105 CFU/mL L. maritima strains
YPC210 and YPC211 in a 50:50 ratio. Treatments occurred weekly both the day
before and the day after feeding. Additionally, 10 lobsters received no treatment. All
aquaria tanks were cleaned once a week to maintain the health of the adult lobsters.
All lobsters showed little/moderate shell disease, while probiotic treatment appeared to
induced both egg bearing and mortality. The trial was discontinued after 12 days due
to 40% mortality with the probiotic treatment group (Table 6). Haemolymph was sent
for pathology to see if the probiotics are responsive for the mortality incurred in this
trial.
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Table 1: Zones of inhibition (mm) from screened lobster isolates (5 µL spot plates)
against Aquimarina sp. strain I32.4, Thalassobius sp. I31.1 and, Vibrio anguillarum
NB10Sm. ZOI assessed by EVOS light microscope (Life technologies). [–] Indicates
that no ZOI was observed blanks indicate that the test has not been done.
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Table 2: Optimizing growth conditions for Aquimarina ‘homaria’. Symbols
correspond with + (Low Clumps), ++ (Clumps), +++ (High Clumps) and + (Low
Growth), ++ (Growth), +++ (High Growth). Data from Edward Spinnard.
Media/Conditions

Growth

Clumps

YP-30 (1µM EDTA)

+++

+++

YP-30 (5µM EDTA)

+++

+++

YP-30 (10µM EDTA)

+++

+++

YP-30 Small Stir Rod

+

-

YP-30 Large Stir Rod

+

-

Marine Minimal Media (3M)

+

-

YP-10

+

-

YP-20

++

+

YP-30 (175 RPM)

+++

+++

YP-30 (300 RPM)

+++

+

YP-30 Static

+++

-

Marine Broth

+++

+++

LB-10

+

-

LB-20

+

-

LB-30

+

-
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Table 3: Data obtained from NCBI for all known Aquimarina genomes and run
through antiSMASH cluster analysis database.* Aquimarina pacifica and Aquimarina
agarilytica possess no know biosynthetic gene clusters (BGCs).
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Table 4: Data obtained from NCBI for all known Thalassobius sp. genomes and run
through antiSMASH cluster analysis database.
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Table 5: Monoculture XAD16 extracts activity against V. anguillarum NB10Sm.
Bacteria were grown in 1L YP30 shaking cultures for 1 week. Cultures contained
XAD16 throughout the growth period. Cultures inoculated from 5 mL broth cultures
with 1 mL of dense cell media.
Strain Identifier

Species

Ha031151216YPC23
Ha061151216YP001
Ha061151216YPC21
Ha061151216YPC22
Ha061151216YPC210
Ha061151216YPC211
Ha091151216YP019
Ha10b1151216YPC21

Alteromonas sp.
Bacillus pumilus YP001
Pseudoalteromonas sp.
Pseudoalteromonas sp.
Loktanella maritima strain YPC210
Loktanella maritima strain YPC211
Shewanella sp.
Cobetia sp.
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Disc Diffusion
(200 µg)

Disc Diffusion
(400 µg)

✓
✓
✓
✓

✓
✓
✓
✓

✕
✕

✕
✕

✓
✓

✓
✓

Figure 1. Overlaid chromatograms for SNP spiking experiment at doses 0, 1 and 10
µM. (A) B. pumilus YP001, (B) Pseudoalteromonas sp. YPC21, (C)
Pseudoalteromonas sp. YPC22, (D) L. maritime YPC210 (E) L. maritima YPC210.
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Figure 2. Growth of putative probiotics by measurement of wavelength (600 nm) as a
proxy for cell density over time. Standard deviation from triplicates calculated for
each time point.
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Table 6: Adult H. americanus trial carried out over 12 days. Data from Kathy Castro,
Barbara Somers, and Mitch Hatzipetro.
Strains Tested
Loktanella maritima strains YPC210 and
YPC211 combined

N of
Lobsters

Mortality (N) of Number of Egg Bearing
Lobsters
Lobsters

10

4

3

Freshwater Scrub

10

0

2

Control

10

0

0

200

Table 7: Single strain testing of potential probiotics against PL lobsters assessing
mortality over 3 days. All putative probiotics were tested at 1x106 cell/mL. Work
carried out by Melissa Hoffman, Kathy Castro, Barbara Somers, and Mitch Hatzipetro.
PL Lobsters Mortality (5 days)
(N)
Trial

Strains Tested

16S Sequence

Ha031151216YP014

Pseudoalteromonas sp.

12

0

Ha061151216YPC22

Pseudoalteromonas sp.

12

3

Ha061151216YP001

Bacillus sp.

12

1

Ha061151216YPC210

Loktanella sp.

12

0

Ha061151216YPC211

Loktanella sp.

12

1

Ha081151216YPC21

Pseudoalteromonas sp.

12

1

S4

Phaeobacter inhibens

12

2
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Table 8. Probiotic treatments of PL lobsters with concomitant challenge with the
putative pathogen Thalassobius I31.1. Mortality was assessed after 3 days. All
probiotics were tested at 1x106 cell/mL. Melissa Hoffman, Kathy Castro, Barbara
Somers, and Mitch Hatzipetro.
Strains Tested
Ha031151216YP014
Ha061151216YPC22
Ha061151216YP001
Ha061151216YPC210
Ha061151216YPC211
Ha081151216YPC21
S4

16S Sequence
PL Lobsters (N) Mortality (3 days)
Pseudoalteromonas sp.
12
0
Pseudoalteromonas sp.
12
0
Bacillus sp.
12
0
Loktanella sp.
12
0
Loktanella sp.
12
0
Pseudoalteromonas sp.
12
0
Phaeobacter inhibens
12
0
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Appendix C: Manuscript 5
Production of known siderophore agrobactin by the marine bacterium Loktanella
maritima YPC211 when grown in co-culture with Thalassobius sp. I31.1 a putative
pathogen involved in lobster shell disease.
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Author Contributions

Bacterial strains were isolated by H.J.R. Antimicrobial testing, chemical isolation, and
genome sequence analysis were carried out by H.J.R. C.P. helped with large scale
chemical extraction and purification. J.L. and E.S. aided in genome sequencing.

203

Additional Results

Loktanella maritima is a Gram-negative, aerobic bacterium originally isolated
from shallow marine sediments in the Sea of Japan (1). The genus is of the class
Alphaproteobacteria, family Rhodobacterales, order Rhodobacteraceae. Von Trappen
et al. (2) originally proposed the genus to accommodate three species but it has since
been expanded and modified to contain 15 species (3-5). Loktanella appear to be
ubiquitously distributed in the oceans and have been isolated from Antarctic to subtropical environments (1,2). The strain YPC211 produces a beige/yellow pigment and
was isolated from the egg mass of an American Lobster Homarus americanus
collected in Narragansett Bay near Jamestown Island, Rhode Island, USA.
No natural products have been isolated from this genus despite widespread
genomic sequencing. We present the first documented natural product, biosynthesis
and bioactivity for this strain. This strain was isolated from eggs, which often retain a
specific communities of microorganisms that contribute to the protection against
infection. Bacteria isolated from crustacean egg masses have previously been found to
produce secondary metabolites that aid in the protection of the eggs. Initial
investigation of extracts from YPC211 monocultures did not yield antimicrobial
bioactivity. Therefore a co-culturing approach was undertaken since such approaches
have previously been successful in activating silent biosynthetic gene clusters (6).

1.1 Sampling and Isolation
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Bacterial isolations were carried out from field collection swabs of live wild
Lobsters in Narragansett Bay (12/16/15; Fort Weatherall, Jamestown, RI, USA) as
outlined in appendix I. This particular isolated was from an egg mass which harbored
a diverse range of antimicrobial producing bacteria and was isolated on YP30 agar
supplemented with chitin (30 g/L) from a 100-fold dilution.

1.2 Genomic Sequencing and Biosynthetic Gene Cluster Analysis

Loktanella sp. constitutes a biosynthetically diverse and relatively unstudied
genus, therefore whole genome sequencing was carried out for strain YPC211 and
published as manuscript 5. A comparison of secondary metabolite gene clusters was
made across the 12 genomes sequenced for Loktanella and available through NCBI
(Table 1). Further computational approaches were used to determine potential BGCs
responsible for the antibiotic effects observed lead to the investigation of a nonribosomal peptide synthase (NRPS) BGC (Figure 1). Sequence antibiotic biosynthetic
cassettes were analyzed for identity through Geneious and NCBI-delta-blastp.

1.3 CAS Iron Binding Affinity Assay

To qualitatively detect siderophore production in Loktanella maritima
YPC211the strain supernatant was tested in liquid chrome azurol S (CAS) indicator. A
CAS solution was prepared according to the reported method (Schwyn & Neilands;
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1987). Overnight liquid cultures grown in iron-limited media were centrifuged 10,000
rpm for 1 minute and supernatant was combined in a 1:1 ratio with CAS reagent.

1.4 Chemical Characterization of Loktanella maritima strain YPC211

Initial screenings outlined in appendix I indicated that the strain YPC211 was
able to produce a ZOI when spot plated against putative pathogens. However, no
monoculture secondary metabolite extract was able to induce a ZOI. To tackle this
problem Thalassobius sp. I31.1 and bacterial isolate Loktanella maritima YPC211
were grown from stock on YP30 agar plates at 25 °C for 48 h. Single colonies were
picked and inoculated into 5 mL of sterile artificial seawater supplemented with yeast
(1 g/L) and peptone (5 g/L) and incubated at 25 ºC with shaking at 150 rpm for 48 h.
Two 2 L Erlenmeyer flasks containing YP30 media were inoculated with 1 mL of
dense culture and allowed to grow under the same conditions for 48 h. Two 50 mL
samples of equally dense cultures of Thalassobius sp. and Loktanella sp. were taken
according to OD600 readings. The Thalassobius sp. was autoclaved and the samples
were centrifuged at 5,000 rpm for 30 minutes. The cells were washed 3 times with
ASW and combined in 1 L of fresh YP30 incubated for 5 days at 25 oC and 150 rpm
(New Brunswick) in the presence of Amberlite XAD-16 resin (Sigma Aldrich).
Resin was filtered through a double layer of cheesecloth, washed with 700 mL of DI
water and dried.
Resin was eluted with a first wash of 250 mL DCM and 250 mL of methanol
followed by 250 mL of methanol. The crude extract was concentrated via rotary
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evaporation. The resulting extract was partitioned between ethyl acetate (EtOAc) and
water 3 times in a 2 L glass separatory funnel. The organic fraction was concentrated
by rotary evaporation before further purification. Preliminary screening for bioactivity
utilized bioassay guided 96 well plate fractionation from the crude extract and tested
all peaks against V. anguillarum NB10Sm. Results from this indicated a single active
peak (Figure 2). The active peak showed a strong 254 nm absorbance used to target it
in further purifications.
Large-scale chemical separation methods are summarized in figure 3. Once the
active peak was established a high throughput targeted fractionation strategy could be
employed using solid-phase extraction (SPE) and carried out on a CombiFlash Rf200
system equipped with a 13 g C18 RediSepRf High Performance Gold column
(Teledyne ISCO). Solvent gradient of 5-100% B (methanol with 0.1% water formic
acid) was run over 28 minutes. The mobile phase was initially held at 95 % solvent A
(water with 0.1% water formic acid) for 4 minutes before starting the gradient and was
held at 100% solvent B for 4 minutes after the gradient was completed. Individual
peaks were collected according to absorbances at 254 nm and then concentrated in
vacuo. This yielded 6 fractions which were further separated using high performance
liquid chromatography (HPLC). HPLC experiments were performed on a Shimadzu
prominence-I LC-2030C equipped with a PDA detector model LC-2030/2040, pump
LC-2030, and autosampler LC-2030. The HPLC method included a flow rate of 1
mL/min, a linear gradient of MeOH against H2O (0.1% formic acid) and an XBridge
BEH 5 µm C18, 130 Å, column (4.6 mm X 250 mm) as the stationary phase.
Chromatography method: 5% MeOH for 4 minutes, linear gradient to 100% MeOH
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over 16 minutes, maintain 100% MeOH for 4 minutes, return to 5% MeOH for 4
minutes.
Chemical characterization of pure compounds was undertaken using mass
spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy and optical
rotations. An accurate mass spectrum for agrobactin was acquired by electrospray
ionization mass spectrometry (ESIMS) using an AB Sciex TripleTOF 4600
spectrometer in the positive ion mode (Figure 4). Validation of agrobactin structure
was carried out by MS/MS fragmentation (Figure 5). 1H NMR experiments were
conducted using a 500 MHz Varian NMR (Varian Inc., Palo Alto, CA, USA) with
DMSO-d6 as the solvent at 25 oC (Figure 6).

1.5 Bioassay guided fractionation, disc diffusion and minimum inhibitory
concentration (MIC) antibiotic determination and quantification

Once purity of the active peak was established (Figure 7) disc diffusion assays
were carried out as a bioactivity guided fractionation strategy. V. parahaemolyticus
was grown from stock on YP30 agar at 25 °C for 24 h, then in 5 mL of YP30 at 25 °C
shaking at 150 rpm for 24 h. The dense culture was spread onto fresh YP30 agar.
Organic fractions were dissolved in MeOH at a concentration of 20 mg/mL and loaded
onto discs at final concentrations of 100 µg and 200 µg, dried, and placed onto the
plate, and the plate was grown for 24 h at 25 °C. Plates were observed for zones of
inhibition (Figure 8).
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Minimum inhibitory concentration (MIC) was determined using a broth
dilution assay in a 96-well plate, methanol was the vector for compound testing, and
ciprofloxacin at 0.4 µg/mL was a positive control. Plate was incubated shaking at
room temperature. Absorbance readings were taken hourly at 600 nm for 24 h
(Spectromax). The MIC of agrobactin (HR1-149-2) was determined to be 50 µg/mL
against V. parahaemolyticus (Figure 9).
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Table 1: Data obtained from NCBI for all known genomes of Loktanella and run
through antiSMASH cluster analysis. *indicates no biosynthetic gene clusters
identified by antiSMASH.
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Figure 1: NRPS biosynthetic gene cluster analysis and alignment to known gene
clusters. Binding pocket sequence analysis was used to predict the substrate
specificity.
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Loktanella YPC211 1L Co-Culture
XAD16 Resin
1:1 DCM:MeOH
Crude Supernatant Extract
Solvent partition between water and EtOAc
EtOAc Extract
Chromabond C18 SPE Vacuum manifold
EtOAc Extract
C18 Reverse Phase Analytical Column 96 well plate fractionation
Lipophilic
Non- Polar

Polar
Well 68

Well 76

Well 77

Antibiotic activity tested against V. anguillarum

C18 Reverse Phase Semiprep purification
HR1-149-1

HR1-149-2

Figure 2: Initial chemical screening, 96 well plate fractionation from crude extract to
identify the peak responsible for the observed antibiotic activity.

213

Loktanella YPC211 10 L Co-Culture
XAD16 Resin
1:1 DCM:MeOH
Crude Supernatant Extract
Solvent partition between water and EtOAc
EtOAc Extract
C18 Flash Chromatography peak collection according to 254 nm wavelength
Lipophilic
Non- Polar

Polar
HR2-23-1

HR2-60-3

HR2-23-2

HR2-60-4

HR2-23-3

HR2-60-5

HR2-23-4

HR2-23-5

HR2-23-6

HR2-59-1

m/z 315 [M+H]+
Agrobactin
369 [M+Fe]+
HR2-62-1 HR2-62-2 HR2-62-3 HR2-62-4 HR2-62-5 HR2-62-6
m/z 479 [M+H]+ NMR m/z 659 [M-H]2 mg
331 [M+2H]+
m/z 407 [M+H]+
NMR
Agrobactin
429 [M+Na]+
2 mg
m/z 115 [M+H]+
3 mg m/z 211 [M+H]+
424 [M+H]+
169 [M+Fe]+
446 [M+Na]+
NMR
NMR
<1 mg m/z 183 [M+H]+ NMR
<1 mg
181 [M-H]- 1 mg
NMR
<1 mg
m/z 849 [M-H]425 [M+2H]+
1 mg

Figure 3: Large scale chemical isolation of agrobactin from a co-culture of Loktanella
maritima YPC211 and Thalassobius sp. strain I31.1.

214

[M+Na]+

[M+H]+

[M+Fe]+

Figure 4: High resolution tandem mass spectrometry intensity from direct injection
ESI in positive ion mode (declustering potential 150 collision energy 30) for
agrobactin m/z 637.2566 [M+H]+, 659.2373 [M+Na]+, and 681.2185 [M+Fe]+.
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Figure 5: Direct injection TOF MS/MS fragmentation positive ion mode of agrobactin
m/z 637.2 [H+H]+ to produce identifiable building blocks and structure confirmation.
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Figure 6: Proton NMR spectrum of agrobactin Varian NMR 500 MHz with DMSOd6 as the solvent at 25 oC.
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Figure 7: Analytical HPLC chromatogram of agrobactin as purified product.
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6 mm
Figure 8. Disc diffusion assay indicating that only crude extracts from co-cultures of
Thalassobius I31.1 and L. maritima YPC211 are able to elicit an antibiotic effect
against V. anguillarum NB10Sm. Positive control is ciprofloxacin, negative controls
are crude media extract and methanol blank. Testing monoculture extracts of
Thalassobius I31.1 and L. maritima YPC211.
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Figure 9. MIC assay for agrobactin (HR1-149-2) against MRSA plotted as averages
and standard deviation * P<0.05 ** P<0.01 from agrobactin (methanol) and
ciprofloxacin (DMSO). Cell density measured by optical density (600 nm
absorbance).
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